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Abstract  •   Summary 	  
Gamification	  in	  the	  Pharmaceutical	  Industry	  	  
 
Concordant with a wider political and cultural emphasis on individual choice and self-
care, European patients have during the last decade become empowered stakeholders as 
a result of digitization. Nonetheless, patient empowerment sits uncomfortable with the 
prevailing business model pertaining to the majority of pharmaceutical organisations 
whose PR activities primarily target healthcare professionals, politicians, and patient 
organisations. This has infused the debate about how the industry can improve their 
interaction with patients while still complying with restrictive legislation concerning 
direct communication with patients. This thesis uses a qualitative approach to investigate 
the possibility of using digital gamification to circumvent this issue and examine how 
gamification can be designed for patients. Focus is on gamified mobile applications used 
by Danish diabetics. It is concluded that in order to successfully design and apply 
gamification in the pharmaceutical industry, several additional features must be 
incorporated in the design, compared to what is argued in the prevailing gamification 
theory. If this is appropriately done, pharmaceutical organisation can use gamification to 
help patients with their illness by motivating them to live healthier lives. Consequently, 
this will increase the trust towards the industry and thereby strengthening its relationship 
with the patient stakeholders. Moreover, gamification also permits those organisations 
that successfully deliver gamified applications to position themselves as market leaders 
among the future key decision makers, as they provide value beyond the pill. Rooted in 
the Organismic Integration Theory and with inspiration from gamification theory, 
psychological theory of motivation, and interviews with patients and industry experts, 
this study proposes an elaborated model of digital gamification in the pharmaceutical 
industry by closing the identified gaps in the existing theory.  
 
 
Keywords: Public Relations, Digital Gamification, Pharmaceutical Industry 	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1. Introduction 	  
	  
1.1 Definition of research problem 
Patient-centricity has recently become a popular topic within the pharmaceutical 
industry (FirstWord, 2013). However, despite the seemingly genuine intentions when 
pharmaceutical organisations place the patient at the heart of the business and claim to be 
transparent, the reality has manifested itself as being far more complex. Bound by local as 
well as global legislations that limit what can and cannot be communicated to patients or 
put in the public domain, the industry has struggled to square demands for more openness 
with regulatory regimes that actively limit the possibility of interacting with end-users of 
medical products (FirstWord, 2014). Regardless of what the industry does its motives will 
inevitably be questioned as long as profit is part of the health equation. Different PR 
activities such as the funding of patient groups and related patient focused initiatives 
leaves organisations operating in the pharmaceutical industry open to a variety of 
accusations such as promoting awareness about illnesses that do not necessarily require 
treatment (Payer, 1992). Nevertheless, the increased demand from patients alongside their 
growing level of authority and access to medical knowledge means that pharmaceutical 
organisations can no longer afford to content them selves with the prevailing business 
model. The patient as a stakeholder is already a reality. The question remains, however, 
how communication and trust is best established with these stakeholders.  
In the context of strategic public relations, gamification has recently been proposed 
as a key tool to build relationships. The purpose of this study is thus to contribute to a 
theory of gamification against the backdrop of a theoretical analysis and with inspiration 
from qualitative interviews and psychological theory of motivation. This theoretical 
contribution will outline how gamification can be applied in the pharmaceutical industry 
and the outcome will be presented in an elaborated model of gamification. The study will 
scrutinize the implications of patient empowerment on the interaction between European 
pharmaceutical organisations and patients. A specific focus is put on Danish patients 
suffering from Diabetes and the ability of the industry to use gamification in mobile 
applications as a PR tool to enhance the relationship with these stakeholders by helping 
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them to manage their own health. Patients’ experiences with using digital gamification are 
analysed to establish how the industry can use this knowledge to build successful 
applications that can improve the interaction with patients. Patients’ opinions about 
gamification in health related apps are compared with the business objectives of applying 
gamification, in order to analyse the outcome of this specific strategy in the context of 
overall corporate goals. 
This study will take a qualitative approach and review theoretical stances in the area 
of gamification. Close attention is paid to the distinction between practitioner-theory and 
empirically tested, academic theory, although both types of theories will be evaluated with 
respect to their plausibility. At the end of the review of the current state of gamification 
theory, deficiencies and gaps will be discussed alongside an analysis of whether the 
assumptions of the authors hold true in the field of healthcare. This analysis and critical 
discussion of identified gaps will function as the overarching theoretical framework of 
this study.  
 
1.2 Research questions 
While the thesis will be guided by the overall topic of digital gamification in the 
European pharmaceutical industry, the study will more specifically attempt to answer the 
following three research questions: 
RQ1: “How is gamification suited for the pharmaceutical industry?” 
RQ2: “How can digital gamification be applied by pharmaceutical organisations to        
improve the relationship with patients?” 
RQ3: “How does the outcome of applying digital gamification in pharmaceutical 
organisations tie back to the business objectives?” 
The first question inquires about the barriers and opportunities for applying 
gamification in the pharmaceutical industry. The answer will be based on the information 
derived from eight interviews together with analysis of theory. The second question 
addresses identified factors in the interview data that are paramount for digital 
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gamification to be meaningful for patients and, consequently, will contribute to good 
relationships with pharmaceutical companies. The focus in the third question lies on the 
business objectives presented during two expert interviews and on relating these to the 
perception of the patients to determine how these two viewpoints match. The three 
questions are interconnected, as the relevance of RQ2 depends on the answers in RQ1 
while RQ1 is partially determined by the answers unveiled in RQ2. The answer to RQ3 is 
based on an evaluation of the degree to which pharmaceutical companies are currently 
capable of specifying how gamification can be made meaningful for patients as addressed 
in RQ2. It is conceded that at present no simple answer exists to the research questions 
and that answering these requires an exploratory approach. 
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2. Industry background 	  	  
This chapter serves as a background discussion of the key concepts related to the 
thesis topic. It will describe and evaluate the history and trends in the pharmaceutical 
industry and examine the market dynamics in order to create a roadmap for further 
analysis. Relationships between pharmaceutical organisations and its various stakeholders 
will be described and challenges as well as opportunities in patient communication will be 
highlighted.  
 
2.1 Patients, physicians, and pharmaceutical organisations 
Less than a generation ago, healthcare professionals like physicians were any 
community’s sole gatekeepers to medical knowledge and insight (Accenture, 2011). One 
would visit their doctor and either follow the advice given, buy the prescribed medicine or 
be referred to a specialist or hospital with whom a similar one-way communication model 
between the patient and the caregiver was quickly established. Results from research 
carried out in the medical field were delivered to the world in a manner that was primarily 
accessible and comprehensible to healthcare professionals. Little contact between patients 
and pharmaceutical organisations existed, particularly due to the strict regulations 
prohibiting direct-to-consumer advertising (DTCA). To date only two nations permit 
DTCA, these being the United States of America (since 1997) and New Zealand (since 
1981).  
This paternalistic model illustrating the asymmetrical doctor-patient interaction 
where physicians use their knowledge and experience to decide on the requisite 
interventions to restore the patients’ health or ameliorate pain is no longer typical (Chin, 
2002). Due to the rapid change in how we communicate and the platforms we use for this 
purpose, healthcare providers and the pharmaceutical industry alike are now facing a 
whole new generation of patients who are much more engaged and take a proactive 
approach to managing their own health (Fokner-Dunn, 2003; Kummervold and Wynn, 
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2012). Via the Internet ordinary people can access a wealth of medical information and 
research and share their subjective experiences and thoughts on treatments. Similarly, the 
strong increased societal focus on health has been important for this growing wish to 
investigate and self-diagnose among the general public, which has turned healthcare into 
self-care. This transition has lead to more autonomous patients who advocate for greater 
control, reduced physician dominance and increased mutual participation (Kaba and 
Sooriakumaran, 2007). Arguably, the power to decide is gradually shifting from 
physicians to a new set of stakeholders who take a greater role in healthcare decisions as 
they actively seek medical information outside their physician’s office. This shift is 
paramount for the public relations strategy in the pharmaceutical industry, as companies 
operating within this domain must embrace a new kind of stakeholder, commonly referred 
to as the empowered patient.  
 
2.2 Industry drivers 
When examining the political, legal, economic, and social milieu of the 
pharmaceutical industry, it quickly becomes apparent that a number of drivers currently 
push the industry towards new horizons. As already discussed, the power to decide is 
changing with the patient-centred approach gaining ground. As the patients become more 
influential, pharmaceutical organisations need to acknowledge the need for re-mapping 
their stakeholders. This also indicates that a sole focus on engaging physicians, 
politicians, payers, governments, patient organisations and key opinion leaders no longer 
suffice. This argument is supported by the medical marketing trends and business leaders’ 
forecasts (see for example thepharmaletter, 1996). They bear witness to the fact that the 
somewhat aggressive sales activities targeting doctors are in decline while more attention 
is focussed on education and promoting dialogues with the patients via online channels.  
Notwithstanding this development, evidence suggests that lobbying of politicians at 
a local and European level remains necessary, as these people eventually create and adapt 
the legislations related to e.g. market access, manufacturing practises, 
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pharmacovigilance1, clinical trials and procedures for the marketing authorisation (cf. EU 
Directive 2001/83/EC and regulation (EC) No 726/2004). According to statistics of the 
EU Transparency Register, spending on lobbying activities in the pharmaceutical industry 
in the European Union exceeded 40 million Euros in 2012. Nearly half of this budget was 
spent on local lobbyists whose goal is to influence key decision makers (Nizinska, 2012). 
It is also noteworthy that many pharmaceutical companies failed to declare their lobby 
activities in the EU Transparency Register and that if the total expenditures were to be 
recorded, it is estimated that this would amount to the level of approximately 90 million 
Euros (Nizinska, 2012). This gap between what is being said and what is being done has 
caused the entire industry to be accused of being opaque and not open to public scrutiny. 
Therefore, it is debatable to what degree this traditional way of lobbying will be extant in 
the future, if not modified to better suit the demands of the patients who in turn influence 
political decisions.  
Apart from adapting lobby activities and constructing a valuable dialogue with 
physicians rather than merely conducting sales activities, it is apposite to suggest that 
cooperation with patient organisations will become increasingly crucial. This argument is 
rooted in the growing emphasis on patient centricity and the fact that patient organisations 
represent the direct voice and ears of the patients. At the same time, patient groups are 
currently the most direct link that pharmaceutical companies have with patients.  
With patients becoming more empowered and hereby having a greater say in 
regards to treatment, there is both an economic, social, and political interest for 
pharmaceutical organisations to engage in a dialogue with this group of stakeholders. 
Building a relationship with the patients will be beneficial for how the company is 
socially constructed by the members of the society to which it belongs. This greater 
amount of trust will be reflected in the political decisions, which in turn will influence the 
companies’ future. However, given the prohibition of DTCA, pharmaceutical 
organisations have to find other ways of interacting with the patients. Thus although many 
pharmaceutical companies are fully aware of this growing call for new measures, the 
solution is not as easy as one could have wished for and patient interaction as well as 
cooperating with patient organisations has its opportunities as well as challenges.  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1 The pharmacological science relating to the collection, detection, assessment, 
monitoring, and prevention of adverse effect with pharmaceutical products (WHO, 2002). 
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2.3 Challenges in pharma-patient interaction  
The European Federation of Pharmaceutical Industries and Associations (EFPIA) 
emphasizes that trust between the pharmaceutical industry and patient organisations is of 
highest importance and that the industry’s primary obligation is to ensure that the 
medicines it produces benefit society (EFPIA, 2015). They further state that in order to 
protect patient interests, the interaction between the pharmaceutical industry and 
physicians must exclude unnecessary non-scientific activities, but ensure that professional 
and meaningful relationships with stakeholders are improved by providing transparent 
data and guarantee ethical practices (EFPIA, 2015). Based on the statements of EFPIA, it 
can be argued that focus ought to be put on creating a relationship with the patients that 
increases trust. Unfortunately, it is only around one fourth of patient interest groups in 
most areas who currently trust the PR activities of pharmaceutical organisations (Staton, 
2014). But as stated by Stanton (2014) it is essential to win over the patients and despite 
the rather gloomy numbers, patients as well as patient organisations are getting far more 
adept at deciphering the degree to which the information they receive rings true to their 
experiences. Therefore being transparent will increase the level of trust.  
Although gaining and maintaining trust is not something unique to the 
pharmaceutical sector, the process of doing so appears to be far more intricate for this 
particular industry for a number of different reasons. Firstly, pharmaceutical companies 
have for many years not regarded consumer trust as being pertinent to their success. After 
all, many pharmaceuticals (i.e. drugs) are indispensible, leaving patients without a choice 
and thereby rendering trust inconsequential (Estafanos, n.d.). However, this rather naïve 
attitude is no longer affordable and as thoroughly pinpointed by the industry media, 
today’s healthcare environment is about choice and patient participation. Additionally, 
competitive products and biosimilars are claiming more market shares while patients have 
the opportunity to share their sentiment online, whether it be positive or negative 
(Estafanos, n.d.). Consequently, the era of instantaneous information and social media 
suggests that trust must indeed be earned.  
Secondly, as also touched upon, there seems to be a historically bad publicity 
related to the pharmaceutical industry’s lack of transparency. The industry has been 
accused of illegitimate contact with authorities and physicians (Nizinska, 2012). Thirdly, 
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Moynihan, Heath, and Henry (2002) posit among others that financial interests inspire the 
industry to make healthy people believe they are sick. They describe the medicalising of 
ordinary life as disease mongering, or put in other words as the widening of boundaries of 
treatable illness as a means to expand markets for those who sell and deliver treatments 
(Illich, 1990 and Payer ,1992). Pharmaceutical companies are actively involved in 
sponsoring the definition and promotion of diseases and therefore numerous people have 
argued that the social construction of illness has been replaced by the corporate 
construction of this (Moynihan et al., 2002).  
Another factor that strongly impedes the creation of trust towards the 
pharmaceutical industry is the opposing interests between the industry and patient 
organisations. Although enough has been written in the industry press to conclude that 
alliances between pharmaceutical organisations and patient groups provide mutual 
benefits (Wyke, 2011), many also indicate that diverse interests hinder transparency 
(Kessel, 2014, Hughes, 2013). Based on a global survey with 850 patient groups, the 
research organisation PatientView estimates that despite the fact that millions of patient 
groups exist worldwide even the largest, most patient-orientated drug companies number 
their affiliations with patient groups in the low hundreds (Wyke, 2011). From reviewing 
the results of the survey, it can also be concluded that a communications revolution is 
gathering pace across the world, with e- and m-health (e.g. microblogs, online diaries and 
mobile apps) arming the patients with tools that enable them to improve self-management, 
conditions and clinical outcomes. Meanwhile, however, most pharmaceutical companies 
still seem to have little idea of how to become involved and instead they develop 
strategies in isolation without feedback from patients and patient groups (Wyke, 2011).  
Finally, there is the balance between providing patient benefits versus meeting 
business objectives. These two goals are not necessarily contradicting, but if attention is 
too evidently focussed on the latter, it may impede the possibility of promoting trust with 
patients. All these hurdles have to be overcome before any pharmaceutical organisation 
can create a dialogue and a relationship build on trust with its patient stakeholders.  
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2.4 Opportunities in pharma-patient interaction  
Despite its many challenges, communicating with patients also implies a number of 
opportunities. Although pharmaceutical companies and patient organisations driven by 
individual patients and experts clearly have some divergent interest, the two parties also 
have shared interests causing various forms of collaboration to have flourished over the 
years (Herxheimer, 2003). Some of the resources that patient interest groups lack, but that 
the pharmaceutical industry can provide, are project funding, information about 
treatments and diagnosis, lobbying for resources to help patients and business know-how 
(fundraising, publicising itself and expanding).  
Pharmaceutical organisations, on the other hand, need help from patients with 
market expansion, more efficient and prompt diagnosis, branding its products and image 
as a socially responsible industry leader and lobbying against restrictive governments or 
health service policies and regulations (Herxheimer, 2003). As previously mentioned, the 
two goals of providing patients with benefits contra meeting business objectives are not 
inevitably at variance with one another. Patient benefits can logically lead to business 
objectives, as if the distributed product is successful, more patients will prefer this over 
competitors’ products, which in turn will aid the company’s brand. 
Another opportunity for pharmaceutical companies, which a strengthened dialogue 
with patients will cultivate, is the potential of growing the pool of knowledge related to 
e.g. patient adherence and preferred communication channels. If more knowledge is 
generated, this opens up for better treatments along with improved product development, 
which will create goodwill towards the industry.  
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3. Literature review 	  
The literature review will assess major theories about gamification and how these 
are related to the pharmaceutical industry. It will conclude with an outline of research 
gaps and propose a method with which this thesis will attempt to close these by originally 
adding to existing knowledge within the field. 
3.1 Gamification: Moving from a broad to an orthodox 
interpretation 
The term gamification originated around 2008 and had by 2010 been broadly 
applied by numerous industries (Lister, West, Cannon, Sax, and Brodegard, 2014). 
Because the usage of gamification has recently spread like wildfire, the original definition 
of the concept has by many users been forgotten, ignored, or simply remains unknown. 
This has lead to market confusion, inflated expectations, and implementation failures. 
Gamification has turned into ‘something involving games in serious situations’, like for 
example the usage of computer games in schools; something that has otherwise been 
known as game based learning (Lieberoth, 2014).  
However, there is a need for clarifying exactly what gamification is in order to 
conduct goal-oriented and critical research. One of the commonly used definitions is 
generated by Deterding, Dixon, Khaled and Nacke (2011), who describe gamification as: 
“the use of game design elements in non-game contexts”. This is also the definition that 
will be used in this research. To better comprehend the core elements of gamification 
Deterding et al. (2011) elaborated on the definition by stating that gamification refers to 
“The use (rather than the extension) of design (rather than game-based technology or 
other game-related practices) elements (rather than full-fledged games) characteristic for 
games (rather than play or playfulness) in non-game contexts (regardless of specific 
usage intentions, contexts, or media of implementation).” (p. 5). 
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3.2 Successful design and implementation of gamification 
Since the term gamification first originated it has been tested, analysed, and 
evaluated in a great number of companies within a large and heterogeneous collection of 
industries. Gabe Zichermann, Chair of the Gamification Summit and CEO of dopamine2 
identifies three drivers of successful gamification: Feedback (desired behaviour should be 
rewarded with e.g. points), Friends (by making it social and creating camaraderie, users 
have a personal investment and motivation for participating) and Fun (people are more 
likely to participate in something they find engaging and fun) (Lee, 2013 and Zichermann, 
2012). Others have added more features to the list such as competition and leaderboards 
(these will promote prolonged participations due to the ability to compare own 
performance to that of others) (Playgen, 2011), levels (these will make the user feel that 
he or she is progressing) (Sillaots, 2014), on-boarding (getting in to the game easily) and 
scaffolding (guiding the user throughout the game experience) (Oxfeld, n.d.). Several 
people also point to the influence of users’ real life perceptions when experiencing 
something as a character or avatar (see for example Kapp, 2012).  
The literature less concerned with the technological game mechanics and tangible 
guidelines indicates that gamification is a cross-disciplinary activity involving both 
technology and design, but also psychology and business strategy. Ergo, the technical 
specifications and design aspects of gamification are not exclusively influencing its 
success. According to Lieberoth (2014), the legitimacy of gamification is to be understood 
as a particular form of behavioural design that explicitly or more wilily makes use of 
some of the same psychological mechanisms as those observed in games. Behavioural 
design covers the broad range of physical and digital design based actions taken to make 
people think or behave in a certain manner. He further states that it is crucial to be aware 
of the target group’s typical motives and behavioural patterns in those situations that you 
wish to influence.  
When going through the typical design instructions and checklists available online 
to guide designers in creating and applying quality gamification, many of the authors 
appear to ignore these psychological aspects that will inevitably influence the outcome. 
This study further identifies a lack of cognizance that ‘fun’, which is described as a 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
2 An American agency creating gamified campaigns for employees and consumers. 
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requirement for success, is an abstract phenomenon, as this emotional response is not 
uniformly precipitated among different individuals. Similarly, it is important to 
acknowledge the fact that not all people invariably respond positively to competition 
(Niederle and Vesterlund, 2011). Besides thinking like a behavioural designer, more 
recent literature and research conducted in the area demonstrate that motivating the user to 
change behaviour is a complex series of steps that cannot be ignored. 
 
3.3 Motivation 
Historically, psychological approaches have focussed on two primary explanations 
for motivation. These are basic biological needs connected to survival and protection (e.g. 
hunger), and extrinsic rewards or punishments (Sansone and Harackiewicz, 2000). 
Nevertheless, humans (and certain types of animals) sometimes engage in behaviours that 
appear to be more harmful than functioning as a means to an outcome and thus cannot be 
explained by either of these two types of motivation. These behaviours seem to be 
associated with positive feelings of enjoyment and satisfaction. Consequently, researchers 
began to develop theories about intrinsic motivation in which the rewards are inherent to 
the activity (Sansone and Harackiewicz, 2000). Accordingly, extrinsic motivation drives 
behaviour due to external rewards or punishment such as monetary bonuses or withdrawal 
of these, while intrinsic motivation refers to behaviours for which there appear to be no 
reward except for the activity itself (Cameron and Pierce, 2002).  
Although much research has been conducted to determine the best type of 
motivation at changing behaviour, the results are ambiguous. In relation to gamification, 
researchers such as Mekler (2014), Hecker (2010) and Nicholson (2012) point out that the 
typical use of external rewards in most gamification models can happen at the expense of 
internal motivation. Although other studies have shown conflicting results, Deci, Koester 
and Ryan (2001) found for instance in their meta analysis of 128 studies in educational 
settings, that almost all forms of rewards reduced internal motivation. If, however, the 
game design elements can be made meaningful to the user through information, then 
internal motivation can be improved as there is less need to emphasize external rewards 
(Nicholson, 2012). Further to this argument, Nicholson (2012) has introduced the issue of 
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‘situational relevance’. With this he propounds that: “having someone else creating goals 
for a user, is akin to an external judge deciding what is relevant to a query” (page 2). By 
not involving the user, it is impossible to know what goals are relevant and interesting to 
the user. As stated by Detering (2011) a practical way to circumvent this problem is to 
allow users to customize their own goals. This, however, engenders a new challenge, i.e. 
to accurately support and guide the user in setting long- and short-term goals that are both 
challenging, achievable and yield the experience of mastery.   
 
3.4 Academic theory 
A number of academic theories and models have been developed since gamification 
first gained attention. Despite gamification yet being in its infancy some of the theories 
are grounded in vigorous research and bear potential for furthering our understanding of 
effective gamification. Amir and Ralph (2014) propose the gamification effectiveness 
theory. The theory posits four key drivers of effectiveness: intrinsic motivators related to 
the Self-Determination Theory (feelings of autonomy, relatedness and competence), 
extrinsic motivation (points, badges, levels and trophies), game mechanics (space, objects, 
actions, rules and skills) and immersive dynamics (factors such as a storyline that affect 
the user’s immersion in the system).  
These drivers are modelled as a multidimensional construct and formative factors of 
feedback, purpose, and user alignment refer to its dimensions. Ergo, to engage effectively 
with the gamified system, feedback must be given to the user after certain inputs. Poor 
feedback can lead to reduction in user participation. User alignment is defined as the 
process of aligning the purpose of the gamified system with the goals of the user. Amir 
and Ralph (2014) further suggest in relation to intrinsic motivation, which must not be 
eclipsed by extrinsic motivators, that autonomy can be realized when users choose their 
own goals. Competence can be supported by providing the user with challenging tasks 
and encourage further training while relatedness can be supported by urging 
communication on a social level. 
Kappen and Nacke (2013) have designed a cumulative gamification model called 
The Kaleidoscope of Effective Gamification by deconstructing gamification in business 
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applications. The authors draw on a number of academic theories including the Self-
Determination Theory (Deci and Ryan, 1985), the mechanics-dynamics-aesthetics 
framework (Hunicke, LeBlanc and Zubek, 2001), which establishes the relationship 
between the designer’s intent and the user’s experience, and game design lenses 
constructed by Shell (2009), which are heuristics that enable gamification designers to 
build purposeful and engaging games. Based on this research they have created a layer-
based model to illustrate the interconnectedness of behaviour change in gamification. In a 
table (see table A) Kappen et al. (2013) describe how the kaleidoscope consists of a core, 
which establishes the nucleus of the player experience. Layers of motivated behaviour, 
game experience, game design process, and ultimately the perceived layer of fun surround 
the core. The outer layer is what the player can see and aesthetically experience in terms 
of the elements created in the other layers. Unless the player experiences motivation 
through a feeling of delight or fun when using the gamified system, the gamification is not 
effective.    
Table A 
 
Layer Attribute Design guideline 
Motivated behaviour  
layer 
Intrinsic motivation Autonomy: 
Evaluate the needs 
to the demographic 
profile to identify 
values of personal 
importance to users 
such that their 
commitments to 
activities are 
internalized. 
 Intrinsic motivation Competence: 
Identify core values, 
which enable users 
to enhance their 
capabilities and 
skills. 
 Intrinsic motivation Relatedness: Create 
the possibility of 
social 
connectedness, 
acceptance, and 
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validation within 
the gamification 
application. 
 Extrinsic motivation Badges, points, 
leaderboards, 
incentives and 
rewards are only of 
limited value. While 
the app can have 
some of these 
extrinsic motivation 
elements, ensure 
that there is an 
experience of “fun” 
and the element of 
surprise in 
procuring these 
elements. Tagging 
along these 
elements for the 
sake of reward will 
add no value to the 
gamification 
application. 
Aesthetic 
representation is 
another important 
factor attached to 
these rewards. 
Game experience layer Actions Identify game 
mechanics, such as 
rules to stimulate 
intrinsic motivation, 
strategies to indulge 
the user in getting 
excited about 
gameplay, and 
sustaining their 
interest throughout 
the game’s duration. 
All the sub-systems 
must integrate well 
with the motivated 
behaviour layer. 
 Challenges Ensure that the rules 
identifying the 
game mechanics are 
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relevant to the 
intrinsic motivation 
elements so that the 
drive to continue 
playing the 
gamification 
application is based 
on the user’s 
internal desires and 
aspirations. 
 Achievements Identify goals and 
objectives within 
the game that 
enhance the 
personal goals of 
the user and ensure 
its conformance to 
the motivated 
behaviour layer. 
Game design layer Interface, mechanics, models, 
principles  
Identify goals 
within each 
subsystem to 
maximize the 
process of 
integrating sub-
systemt to create a 
fun experience for 
the user, while 
ensuring 
motivation. 
Perceived layer of fun “Fun” Identify the 
perceived layer of 
“fun” such as 
excitable attributes, 
elements of surprise 
characteristics, fun 
in accomplishing 
milestones and the 
of exciting 
hypermedia effects. 
These would 
influence and 
motivate the 
behaviour. 
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3.5 Gamification and patients 
As previously discussed, the trend towards making healthcare fun and engaging is 
being driven by the e- and m-health movements, the rise of the empowered patient and the 
societal focus on disease prevention and patient centricity (Megget, 2014). The 
pharmaceutical industry needs to realize that more and more people’s lives are supported 
by electronic processes and communication. 
 Accordingly there is reason to argue that the industry essentially has to speed up 
and enter the digital era the same way most other industries have already done, if they 
want to reach out to the patient where they are. The potential of digital gamification in the 
pharmaceutical industry is manifold; it can be used to engage, educate, persuade and 
motivate healthcare professionals, patients and the public. It provides the pharmaceutical 
industry with the possibility of communicating with patients while still complying by 
local regulation. It can be applied for crowd sourcing scientific research, detecting 
illnesses faster, patient adherence and tracking patient health (Megget, 2014). However, 
attempting to focus on all opportunities at once is not within the scope of this research. 
Focus lies on the potential of using digital gamification as a PR tool to enhance patient 
relations and build trust by involving and motivating the empowered patients to manage 
their own health. Arguably, the industry has several reasons to do so. 
For example, a group of scientists from Harvard Medical School reported in May 
1998, in the Journal of America Medical Association, that only 52% of patients on 
cholesterol lowering medication renewed their prescription after five years (Kelstrup, 
2006). Pharmaceutical organisations lose a potential income because patients do not finish 
the recommended therapy. This testifies to the necessity of educating and motivating 
patients to improving compliance, not only for the benefit of the organisations, but also 
for the patients’ own sake. Consequently, pharmaceutical organisations become 
meaningful players for the treatment rather than merely functioning as the suppliers of 
medicine. 
Although digital gamification can possibly improve the interaction between the two 
parties, the paucity of empirical research implies that scholars still only have a vague idea 
if, how, and why gamification may work differently when applied on patients compared to 
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healthy individuals. However, some research has been carried out in related fields. 
Glasemann and Kanstrup (2011) conducted a study to establish how mobile technology 
can support young people living with Diabetes. The results indicated a concrete 
importance of these people’s emotions and perspectives on their own illness for the design 
of mobile technology support.  
Lister et al. (2014) carried out one of the first comprehensive reviews of 
gamification use related to exercise and diet. They examined gamification in 132 health 
and fitness apps as a potential influential component of consumers’ health behaviour. 
Although their results showed that some components of gamification in health and fitness 
apps have become immensely popular, there appeared to be a lack of integration of 
important elements of behavioural theory from the app industry, which may impact the 
efficiency of gamification on behavioural change (Lister et al., 2014).  
Although some studies have already examined certain facets of digital gamification 
in the healthcare industry, these have taken a quantitative approach, neglecting the need 
for creating a deeper understanding of how and why patients respond in specific ways to 
gamification and whether this affects their relation to the pharmaceutical industry. By 
generating this knowledge, the industry will be much better positioned when creating 
gamified apps for patients.  
 
3.6 Identified overarching theories 
When reviewing the major theoretical positions, it is clear that these are all linked to 
a number of dominating theories. Through analysis of these, this study proposes that three 
overarching theories guide the academic arguments. Firstly, the majority of authors base 
their approach on The Self-Determination theory. This macro theory focuses on the 
degree to which an individual’s behaviour is self-motivated and self-determined (Deci and 
Ryan, 2002). It assumes that conditions supporting the individual’s experience of 
autonomy, competence, and relatedness will foster the most volitional and high quality 
forms of motivation and engagement for activities, including enhanced performance, 
persistence, and creativity (selfdeterminationtheory.org, n.d.). It states that humans are 
active organisms with natural tendencies toward growing, mastering ambient challenges, 
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and integrating new experiences into a coherent sense of self 
(selfdeterminationtheory.org, n.d.). The theory further suggests that the more internalized 
the extrinsic motivation the more autonomous the person will be when enacting the 
behaviours.  
Regarding the three core conditions, autonomy in gamification describes the ability 
of users to set their own targets that are of value to them because without some level of 
freedom it will be tasking to cultivate motivation and perseverance. When the user is a 
patient it is much more speculative to what degree of autonomy these people can have. 
Diabetics are restricted by their condition and therefore cannot enjoy the same level of 
freedom to set goals, as these could possibly compromise treatment. The argument then is 
whether or not autonomy can be applied on an equal footing in pharmaceutical 
gamification as in other sectors.  
The second condition (competence) is related to the feeling of mastery as the player 
progresses from beginner to expert level. While this may hold true for regular users where 
focus is on the achievements in the game, this research further proposes that the feeling of 
mastery in the app must reflect the feeling of mastery in the patients’ real lives, as their 
focus is arguably more on this than on the gamified system per se.  
Relatedness, the third condition, is being part of a social network via the app, in 
which the user can feel accepted. Regarding the pharmaceutical industry, there is reason 
to believe that relatedness may either be even more crucial for gamification to be 
meaningful for the patients, as patients are an isolated group with a greater need for 
feeling that they belong, or less important because they are more preoccupied with their 
condition than with engaging in social platforms. Arguably, the right social dimension 
will be beneficial for effective gamification, while relatedness when not applied with 
respect to the patients’ circumstances may be an unessential surplus feature. 
The second overarching theory to which this study links most of the theoretical 
positions is primarily connected to the isolated gamification success criteria suggested by 
practitioners and experts and not to theories of intrinsic motivation. Most of these are 
rooted in The Theory of Operant Conditioning proposed by Skinner (1938), who based 
much of his work on Thorndike’s law of effect (Thorndike, 1927). According to operant 
conditioning a subject is encouraged to associate desirable or undesirable outcomes with 
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certain behaviours. The theory disregards innate needs and focuses solely on external 
reinforcement to shape motivation and behaviour.  
As seen in gamification, the conditioned reinforcements, which are typically points, 
badges, or other rewards are learned and thus become motivators. These assumptions may 
be supported in other areas, but when applied to healthcare situations additional 
consideration is most likely required. Given the circumstances, external rewards may no 
longer be sufficient motivators for behavioural change in patients. This argument is based 
on the conjecture that the external rewards or punishments in the app ought to be 
supported by rewards and punishments in the patient’s real life for the tasks to be 
meaningful. Although gamification in other industries also links the features of the app to 
the user’s real life, it is here argued that this link needs to be fortified by means of a 
comprehensive analysis of all influencing factors in the patient’s life, to understand how 
their condition and treatment can be tied to the rewards and punishments in the gamified 
app. This argument rest on the fact that patients oftentimes deal with things affecting their 
entire life and body, and thus their lifestyle, whereas gamification applied in other 
industries may only focus on isolated behaviour. This could for instance be keeping your 
electricity usage below a certain limit for three months consecutively, which will then be 
rewarded by the electricity company who plants 10 m2 rainforest in your name (Lieberoth, 
2014).  
Finally, many of the theoretical positions are connected to a third overarching 
theory called the Social Exchange Theory (Emerson, 1976). This theorizes that subjects 
will base their decisions on a cost-benefit analysis. The theory posits that individuals will 
repeat actions that they are rewarded for if they outweigh costs, which is aligned with the 
practises of gamification (e.g. go for a run every day and be rewarded with 10 points). 
Gamification is successful at spurring engagement because it amplifies the worth of 
engaging in certain tasks and increases the user’s sense of personal investment (Jong, 
2014).  
This theory is not only related to the tangible rewards such as points, but also to the 
social network described by several authors. If an individual is invested in their social 
reputation, they are likely to be driven by reputational rewards, which in this instance 
would be a leaderboard that rewards high performers. In extension to the theory, this 
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study also argues that the key to driving engagement is identifying appropriate rewards for 
the target user, which in this case is a patient. 
 
3.7 Summary 
Gamification and its potential within the pharmaceutical industry has been 
discussed. The concept of gamification, which was defined as the use of game design 
elements in non-game contexts, is to tap into the basic desires of all individuals’ impulses. 
These naturally tend to revolve around competition, status and achievement and are 
something embodied in us all (Playgen, 2015). Experts and academics describe several 
design and game mechanic elements as crucial for creating successful gamification. These 
include scoring systems, social interaction, fun, competition, leaderboards, levels, on-
boarding, scaffolding, having a storyline, goal setting and having an avatar. It was argued 
that the gamified system should allow customization, such as choosing your own goals, 
but that this may prove difficult for patients. Moreover, internal motivation will be 
improved if the game is made relevant for the user through information.  
Academic theories outlined how success depends on various drivers of 
effectiveness. These included receiving feedback, aligning the purpose of the gamified 
system with the goals of the user and designing gamification based on interrelated layers 
of game mechanics, external motivation, internal motivation and a perceived layer of fun. 
It was also argued that gamification includes a number of psychological concepts, 
especially regarding motivation. Accordingly one needs to think like a behavioural 
designer and understand these concepts in order to accurately map target group 
expectations and scientifically test the effects of gamification (Lieberoth, 2014).  
One of the main themes in the gamification literature is that gamification can be 
used to encourage certain behaviours and increase involvement my means of applying 
external motivators that relate to our innate drive to compete, to feel part of a network, 
and to be rewarded. Although motivating behavioural change and increased involvement 
among patients are desirable, it was questioned to what degree regular, unadjusted 
gamification systems can be applied in the pharmaceutical sector.  
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Three overarching theories were identified as the majority of the theoretical 
positions were related to these. It was further argued that none of these overarching 
theories could accurately explain how gamification works in the pharmaceutical industry. 
None of the research about digital gamification and patients gives a detailed account of 
target groups, addresses how gamification will influence the attitude towards the industry, 
whether general gamification theory can be applied or how gamified systems ought to be 
altered according to the patient stakeholders.  
These research gaps will be confronted in this qualitative study to create a more 
comprehensive model of gamification in the pharmaceutical industry and establish the 
usefulness of this tool in relation to public relations. On an extract level one can argue that 
for the gamified system to be successful, this externally induced system must be 
incorporated in the patients’ own internal system to restore this, as it lacks the capacity to 
control health. Once the external system is fully integrated into the internal system, 
gamification is successful and can become part of a pharmaceutical organisation’s PR 
strategy.  
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4. Research approach 	  
	  
This thesis takes an inductive research approach by starting with investigating and 
aims at formulating a model based on the results of the investigation. It moves from a set 
of specific observations to the discovery of a pattern that represents some degree of order 
among the given situation (Babbie, 2014). In comparison to a deductive approach that 
aims at testing a certain theory and starts with a hypothesis, the inductive approach was 
deemed more appropriate for this qualitative study, as it allows for an exploration of a 
previously researched topic (gamification) from a different perspective (healthcare).  
 
4.1 Scientific standpoint  
For this research, the theoretical contribution takes inspiration from three sources: 
Gamification theory, psychological theory of motivation, and interviews. While the 
theoretical contribution is based on these three sources, the interviews are rooted in 
constructivism. This paradigm was chosen as inspiration due to its’ emphasis on real life 
relevance and the fact that a constructivist researcher recognizes that people form 
subjective understandings of their experiences and the world in which they exist (Young, 
n.d.). Whereas a post-positivist may employ deductive methods in order to reduce ideas to 
a small set of testable variables that constitute a hypothesis, a constructivist will search for 
patterns of complexity in order to generate new models or theories (Young, n.d.). As 
stated by Creswell (2003), the constructivist researcher asks general, open-ended 
questions allowing participants latitude to express meaning therein. Through this dialectic 
process, these expressions can be compared with other observations to produce 
interpretive notions of reality. Although inspired by constructivism, this research does not 
strictly abide by the principles of this paradigm, as two additional sources form the ground 
on which the theoretical contribution is founded. Rather, the core assumptions are 
supplemented with other analytical tools to produce more substantial claims (Finnemore 
and Sikkink, 2001).  
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Choosing a qualitative method was done deliberately to deepen the understanding of 
how gamification can be used as a PR tool in the pharmaceutical industry. A quantitative 
approach and methods pertaining to this would have yielded different findings unable to 
reveal the underlying factors that form the subjective opinions and attitudes in patients 
and how these match the expectations of the experts. The chosen research strategy has 
naturally led to certain techniques offered by the paradigm. True to the constructivist 
approach and the qualitative methodological underpinnings of this, interviews are being 
conducted with patients and experts from the pharmaceutical industry. 
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5. Methodological protocols 	  	  
Question guideline sheets tailored to each of the participants were made and used by 
the interviewer doing the semi-structured interviews, to ensure that these were kept 
somewhat structured and focussed on the relevant topics. The question guidelines can be 
found in appendix A-C. In order to obtain the sought information without asking leading 
questions or excessively directing the conversation, the researched questions were all 
answered by means of asking interview questions. Below is an example of how the 
questions asked during patient interviews were structured according to the researched 
questions, which were not asked during the interview. 
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Table B 
Researched question Interview question 
 • Why does/doesn’t the app make it easier 
for you to live with your illness? 
 
When does 
gamification motivate 
behaviour? 
• What is the funniest part of the app? 
Why? 
 
 • How do you feel when your 
measurements aren’t close to your goals 
or recommended goals? 
 
Does rewards increase 
extrinsic motivation on 
the expense of intrinsic 
motivation? 
Have you ever experienced a conflict 
between what you wanted to do (e.g. eat 
some cake) and what you had to do to 
reach your target (not eat some cake)?  
 
 When you use the app, is it then primarily 
in order to make your graphs or score 
look better or is it because of your goal to 
become healthier? 
Does the outcome tie back  
to the business objectives?  
 
Do you think that the developer is trying 
to help you manage your health? 
  
What do you think the pharma industry 
gains from developing apps like this, 
which are free for patients to download? 
 
 
5.1 Data transcription 
A complete transcription and translation from Danish to English was carried out of 
one of the interviews (See appendix D). Due to a limited time frame, only relevant 
sections were transcribed and translated in the remaining seven interviews. The 
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transcriptions allowed for an interpretation of the material, which made it possible to 
identify those parts of the interviews that were deemed relevant for the research questions. 
The interviews were taped and transcribed verbatim to ensure that no pivotal content was 
lost. Subsequently the data was reduced and organised to identify emerging themes, 
topics, and patterns (example in table C). The categories are analyst-constructed as the 
researcher attached labels to observed recurring descriptions or tendencies. Owing to the 
relaxed tone of the interviews, much spoken language and words such as ‘hmm’ and ‘ehh’ 
were used in the conversation. In the complete transcription these words are retained, 
while however for the quotations used in the analysis, verbatim transcribed sentences that 
may cause confusion are slightly rewritten to clarify the true meaning.  
Table C 
 
5.2 Ethical issues 
Throughout the interviews the inquirer did not further marginalize or disempower 
the participants whose anonymity was protected if they were patients. This was deemed 
particularly important because the majority of the interviewees belong to a vulnerable 
population and were encouraged to talk about a personal and perhaps sensitive topic. To 
Quote Topic Theme 
“By making your health 
information more available 
to you, then people will 
take much more 
responsibility for their own 
health”. 
Drivers of digital 
gamification 
Awareness 
“Typically, I have an idea 
as to what may be wrong 
with me before I see the 
doctor. If I experience some 
kind of symptom, I’m 
usually able to relate it to 
something. And if there is 
something I’m unsure about 
I Google it”. 
Drivers of digital 
gamification 
Empowerment 
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address this matter all participants signed an informed consent form prior to engaging in 
the research, that they understood the aim of the study and that their rights were protected 
during data collection. See appendix F and G for copies of the consent forms.  
Another ethical principle that is considered in this research involves data 
interpretation. In qualitative research it is expected that data is analysed in a manner that 
avoids misstatements, misinterpretations, or fraudulent analysis. The data must fairly 
represent what is observed (Lichtman, 2010). However, it is here acknowledged that 
taking a completely objective stance is unrealistic in qualitative research, as the 
researcher’s own lens will influence the data interpretation. Qualitative methods have 
been criticized for their subjective analysis, but also their inability to replicate 
observations (reliability), to obtain correct impressions of the phenomenon under study 
(validity), and the reactive effects of the researcher’s presence on the situation or 
individual being studied (Kirk and Miller, 1986 and McRoy, n.d.). Nonetheless, 
qualitative research allows for a more detailed scrutiny as long as the researcher engage in 
self-examination on a continuous basis to ensure that no biases or stereotypes influence 
the interpretation.  
Moreover, quantitative research also accommodates unavoidable weaknesses. Like 
qualitative data analysis is subjective, so is the interpretation of quantitative findings. 
Furthermore, there is a lack of detail in quantitative research and the results may be 
misleading due to missing, influential variables. Accordingly, both qualitative and 
quantitative methods have strengths and weaknesses and each must be chosen according 
to the nature of the inquiry.  
 
5.3 Limitations 
Although conducting interviews allows the interviewees’ subjective understandings 
to be apperceived, this method is limited by the fact that no conclusions can be drawn 
based on a single person’s statement. This research concedes that statements expressed in 
interviews can solely be used for validating or rejecting theories and beget new theories, 
which can then be tested.  
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5.4 Focus area 
5.4.1 The illness 
In order to generate the most valid and reliable results attention is only focused on 
one illness. Diabetes (type-1 and 2) is chosen for several reasons. Total deaths from 
Diabetes are projected to rise by more than 50% in the next 10 years, with over 80% in 
upper-middle income countries (WHO, 2006). There are approximately 60 million 
diabetics in the European Region (10.3% of men and 9.6% of women). The prevalence of 
Diabetes is increasing among all ages in Europe, mostly due to increases in overweight 
and obesity, unhealthy diet, and physical inactivity. Diabetes is therefore a serious illness 
that requires attention. For an in depth description of Diabetes as well as the aetiology, 
risk factors and possible treatments see appendix G. 
 
5.4.2 The participants  
Six Danish patients were chosen for this research, all of who suffer from Type-1 or 
Type-2 Diabetes. It was decided to limit the interviews to Danish diabetics, to improve 
reliability. Despite the two types of Diabetes being inherently different these are 
oftentimes treated identically, like the patients also typically encounter similar challenges. 
It was therefore decided that both types of diabetics could participate on the premise that 
they underwent similar treatments. All of the patients currently use or have previously 
used one of the three gamified apps investigated in this study. To protect the anonymity of 
the patients, their initials rather than their full names are used for reference purposes. 
Furthermore, two expert interviews were carried out with relevant people from companies 
behind gamified apps. This was done in order to reach a deeper understanding of the 
reasoning and motives behind the creation and design of digital gamification in the 
pharmaceutical industry and to evaluate how this matches the needs and thoughts of the 
patients. Both of these experts were chosen due to their expertise in the area. They each 
work within or with the pharmaceutical industry and have both been part of the design and 
implementation of tools containing digital gamification. Accordingly they were able to 
deliver the sought information regarding the intentions and thoughts behind the usage of 
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gamification. See appendix H for an overview and description of the six patients and the 
two experts.  
 
5.4.3 The gamified system  
Gamification is not limited to the digital realm. Nonetheless, it is within this domain 
that it has most often been applied, hence why there is more literature about this and the 
persuasiveness of games (see for instance Ian Bogost’s discussion about procedural 
rhetoric and the expressive power of videogames (Bogost, 2007)). Due to this, and the fact 
that one of the driving forces behind patient empowerment is the increase in digital tools, 
focus is placed on digital mobile applications, otherwise known as apps. This decision is 
also justified on the rationale that if a broader spectrum of gamified systems was to be 
explored, the validity of the results could suffer from the heterogeneous nature of the 
diverse types of activities in which gamification can be applied. 
 
5.4.4 The applications 
Three gamified applications were chosen for this analysis. The apps are positioned along a 
continuum depending on how many gamification elements they possess (see figure B). In 
the low end Dia+ is placed with only a few factors in the app being related to 
gamification. HabitRPG is placed in the high end, as this app resembles a normal game to 
a much higher degree than the other two apps being analysed. HealthSeeker is placed in 
the middle of the continuum. In depth descriptions about the three applications can be 
found in appendix I.  
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Dia+	   HealthSeeker	   HabitRPG	  
Figure B 
	  
Low	  gamification	   	   	   	   	   	   	  	  	  	   	   High	  gamification	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6. Empirical data analysis 	  	  
The analysis of theory along with the formed impressions about the investigated 
topic during the interview processes has enabled a number of central themes to be 
identified, which are useful for answering the research questions. The structure of the 
following chapter is composed on the basis of five main categories under which each of 
the themes are presented and the interviewees’ associated statements are preseneted. The 
data analysis will provide a descriptive account of the findings, which will be followed by 
an in depth discussion about the implication of these on the research questions. All quotes 
that are not directly cited in the text are referenced to in appendix J. In the transcripts the 
following annotations are used: 
… Three dots indicate a pause in speech. 
[…] Three dots in brackets indicate that a chunk of irrelevant words has been removed.  
 
6.1 Drivers of digital gamification 
6.1.1 Empowerment  
It is inevitable that online channels have made it easier for patients to access 
information about health and treatments. Not only has this made patients more 
knowledgeable, but it has also qualified them to question diagnoses and therapies 
proposed by their caretaker, despite these still being commonly perceived as the 
trustworthy expert. L.E.W.H. states that: 
“Typically, I have an idea as to what may be wrong with me before I see the doctor. 
If I experience some kind of symptom, I’m usually able to relate it to something. And if 
there is something I’m unsure about I Google it. But having said that I trust my doctor to 
know more about these things than what I can read myself. Hypochondria starts one 
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place, right, and that’s if you seek too much information, because then all of the sudden 
you have seventeen different illnesses that matches your three symptoms.“ 
There is a clear tendency to seek information online prior to seeking advice from 
physicians. However, this is not done without precaution. As described by many of the 
patients, they remain critical of the sources and prefer to gather information from 
professional websites rather than searching on private blogs or forums (cf. quote 
compilation A). 
 
6.1.2 Awareness  
With the digital development and the concomitant availability of information about 
illnesses, causes, symptoms, and treatment follows a natural increase in the number of 
people who become aware of their health. As expressed by Martin Simon Jørgensen:  
“By making your health information data more available to you, then people will 
take much more responsibility for their own health and go that extra mile, because the 
less transparent it is, the less up in your face, the easier it is to brush aside.” 
The step towards increased awareness accelerates increased action, which is 
particularly important in the healthcare sector where patients’ lives may depend on taking 
action. However, just because the patients are aware of their condition, there is no 
guarantee that they follow a treatment. As illustrated in quote compilation B, diabetics 
encounter numerous every day challenges that keep them from being compliant. The 
industry needs to be familiar with these challenges in order to create a gamified system 
that focuses on the right issues. Gamified health apps can be used to further raise 
awareness and function as a reminder. J.E.S. exemplifies this with the app HealthSeeker:  
“One of the best things about HealthSeeker is its ability to push my focus onto my 
good habits such as eating many vegetables and a lot of whole grain”. 
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D.S.P. who uses HabitRPG states that: 
“I enjoy setting goals and creating this overview over, well, my goals, my daily tasks 
and my habits, so that you can see what you are actually doing during the day. To begin 
with I actually perceived myself as someone with no bad habits, but when I sat down and 
started to add them in the app, I suddenly became aware of all these things that I do, 
which I probably shouldn’t be doing. It gives you a better picture of those things and then 
it’s easier to actually do something about it”. 
Gamification not only engenders awareness about the illness. It also holds the 
potential of generating awareness about the organisation, which combined with illness 
awareness will increase the user base of a particular product. Martin Simon Jørgensen 
says that: 
“When it’s a company like AstraZeneca making the app, then their reasoning is that 
they can get their name flagged and create some awareness about the company. But it can 
also be a plus for them to catch the attention of diabetics who don’t know yet that they 
suffer from this illness, getting them started buying the medicine. […] So there is a 
noticeable sales or market growth in creating awareness. You need to be converted into a 
patient, or buyer of insulin... This business game, it’s a race for the companies about 
getting this established and creating security and of course getting a critical mass. In 
every business it’s a greater battle to win over clients from competing companies than it is 
to draw in someone who aren’t already loyal to a certain brand”. 
Both Martin Simon Jørgensen and Andreas Dam point to the fact that creating 
awareness is a multifaceted undertaking for pharmaceutical organisations. Awareness 
about illnesses leads to more patients being detected and awareness about the brand as 
part of the company’s CSR strategy can increase trust and make them the preferred 
supplier.  
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6.1.3 Sub-conclusion 
As discussed in the literature review, people have become autonomous in relation to 
their health, which has been driven by increased awareness. The interviewees validated 
this point. Digital gamification in the pharmaceutical industry is a natural by-product of 
this development and presents a win-win situation as both the public and the industry has 
something to gain from it. Pharmaceutical organisations have realised the market 
potential, while the public embraces this trend that is perfectly suited for their online 
lifestyles. Ergo, available online information has equalled increased awareness, which in 
turn has equalled increased action. Patients, however, do not consistently act on the 
knowledge they gain, as their internal system may fail to fully control the factors that 
influence their illness and health. Gamification, if constructed with patient challenges in 
mind, then functions as an external support system by means of creating a platform on 
which the patient can take better control over their illness. 
 
6.2 Gamification design 
6.2.1 Competition 
Similarly to healthy people, patients generally find pleasure in competing. However, 
external rewards such as points and batches do not seem to be the main drivers of this. 
These features are positively associated with individual goals and tasks where no external 
competitor is involved, as they function as indicators of progress. Competition between 
two parties, on the other hand, are motivating due to the positive feelings associated with 
winning and negative feelings associated with losing. J.E.S. states that: 
“I enjoy the community in HealthSeeker because I can see how other people do and 
I sort of like to compare my own achievements with theirs”. 
R.H.K. also describes that: 
“If I compare my score to my competitors’ scores, I tend to sign up for an extra 
mission if I’m not satisfied with my position in the leaguetable. Being in an good position 
also makes me eager to keep that.”  
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As seen in the above, motivation related to competitions primarily stems from the 
internal rewards and the feeling of joy rather than external rewards such as points, while 
external rewards appears to be more motivational in relation to individual goal setting.  
 
6.2.2 Customized goals 
Defining goals generally appear to be motivating for patients, as they need 
something to work towards. However, defining goals is a complicated procedure that 
needs careful consideration. As previously argued, it is problematic if a user is not 
involved in goal setting as it is impossible know what goals are relevant to a user's 
background, interest, or needs. In a point-based gamification system, the meaning of 
scoring points is futile to a user if the activity that the points measure is not relevant to 
that user (Nicholson, 2012). Preferably goals must be identified to maximize the process 
of integrating these to create motivation as stated in the Kaleidoscope of Effective 
Gamification. This issue is illustrated in Dia+, where recommended goals are standard for 
all users: 
“I think that the recommended goals are good as guidelines, but they don’t really 
say anything about the individual patient. I know for a fact, that because I run a lot, these 
goals are not really perfect for me. Then it’s nice to be able to adjust them, as you can’t 
generalize among diabetics”. M.W. 
However, if allowing users to customize their own tasks, this may result in a lack of 
long- and short-term goals that are both challenging, achievable and yield experiences of 
mastery (Detering et al., 2011). In HabitRPG users are free to set their own goals, with 
only a few examples that are preset in the app when you download it. Several of the 
patients describe how it is difficult to be creative and set goals that are not obvious or dull. 
Thereby, guidance is a prerequisite for customization. HealthSeeker proposes a golden 
mean and manages to overcome the issue of individual goal setting by letting the user 
choose their own goals but only from a predefined range of goals related to one of the 
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app’s four focus areas3. This position between the other two extremes appears to be ideal 
for fostering motivation: 
“HealthSeeker lets you define your own goals, or rather, you can choose your goals 
from a list of different goals. That’s pretty great because you have some guidelines and 
get some ideas, but you can still customize your tasks. It’s like having a menu card where 
you choose a starter, a main, and a dessert. Here’s the list, be inspired”. J.E.S. 
 
6.2.3 Guidance 
As already stated, guidance of the user is closely related to customization. If the 
patient is to customize goals, then the patient must be guided to do so for the goals to be 
meaningful. This is particularly important in the pharmaceutical industry because despite 
many of the users being empowered they are a special group with more specific needs 
(see quote compilation C). Nicholson (2012) described that game design elements can be 
made meaningful to the user through information, which will lead to improved internal 
motivation. Nicholson’s view on this is supported by the patient’s positive commentaries 
about HealthSeeker’s way of providing information when missions are chosen. For every 
mission that is picked by the user, information follows about the purpose and benefits of 
finishing the mission. This way, they are guided through the app’s missions and 
understand why they do should pursue the goals they are urged to pursuing.  
 
6.2.4 Social dimensions 
Both of the experts acknowledge the need for social interaction on a two-
dimensional level for the gamified system to be meaningful. The two dimensions are 
related to the interaction and sharing of information; one with other patients and one with 
healthcare professionals (cf. quote compilation D). For the latter this provides the patients 
with a storyline enabling them to have a quality dialogue with their physician. For the 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
3 Healthy living, maintaining a low weight, controlling Diabetes and eating nutritiously. 	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former, this allows patients to share their thoughts about their condition with like-minded. 
Moreover, it creates an environment with shared values and perceptions of success, 
meaning that the external rewards will lead to more recognition from the others in that 
environment: 
“If you are in a community, which has some common values about something being 
good and if you then translate that into for example some point-based system, then it 
almost goes without saying that those who have the higher score, they get recognition 
from the others in the community and everybody wants that”. Martin Simon Jørgensen. 
This argument is supported by the views of the patients. For example J.E.S. describes that: 
“Seeing how many points other people have makes me feel like I’m part of 
something. I’m not on the journey alone, you know. Normally I don’t have a lot of contact 
with other diabetics, none of my friends have it, so that cohesion between the players is a 
good feeling. […] It’s fine that you can share your progress on Facebook and earn extra 
points, I do that sometimes, but what I really like is the sort of data interconnection… 
There is something called ‘cure for you’, I think that’s the public one, where the doctor 
can log on and you can log on and then you have your digital journal. And the more the 
app can incorporate this social dimension or interaction into your treatment the better. I 
find it motivating to think that my data can also be used in the bigger picture and find out 
if there is a connection”. 
 
6.2.5 Sub-conclusion 
Social networks, one related to other patients and one related to professionals, each 
leads to motivation to change behaviour but through different routes. Competition 
amongst patients is reinforced due to the social network of like-minded. Common values 
result in greater appreciation and acknowledgement from fellow patients, which translates 
into internal motivation. Interestingly, there is no clear link between external rewards and 
motivation in situations of social competition. On the contrary, external rewards promote 
motivation if these are used in relation to individual goal setting, as these are easy to grasp 
and thus fortifies the individual overview of progress. Goals must be chosen by the patient 
Page	  46	  of	  115	  
but guided by the app. Moreover, the user must be informed of the reasoning behind the 
goals and their benefits.  
 
6.3 Motivation 
6.3.1 Internal-external dichotomy 
Contrary to what some academics have suggested, nothing in this research suggests 
that external motivation happens on the expense of internal motivation. Rather, two things 
may be concluded about the relationship between intrinsically and extrinsically 
motivating factors. Firstly, it appears to be of utmost importance that the internal and 
external motivational drivers are linked. Thus being rewarded or punished externally with 
e.g. points must be linked to an internal feeling in real life. Secondly, it can be argued that 
in situations where external and internal drivers are dissociated, gamification appears to 
bridge the gap between the two, as long as the before mentioned condition is fulfilled.  
“It’s easy to think that all actions should be driven by internal motivation but I don’t 
think that that’s ever going to happen. Gamification is a bridge between the external and 
the internal factors so it will never be the doctor who forces you to do something, but you 
do that same thing on other premises, because it’s fun”. Andreas Dam. 
J.E.S. describes a situation where the gamified app encourages behavioural change 
in a situation with dissonance between internal and external motivation, because the two 
drivers are linked. As seen in the quote, the app enables the patient to align immediate 
desires with what will create a better feeling in the long run: 
“I do experience conflicts between what I want to do and what I have to do to finish 
a mission in HealthSeeker. But even though I sometimes do decide to eat that piece of 
cake anyway, then I think that the first step to changing a bad habit is to make your self 
aware of its existence… And by having this inner conflict I definitely weigh up the long-
term losses with the short-term win and I start to think about something pointed out to me 
by HealthSeeker that I probably wouldn’t have thought too hard about before…I loose 
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experience points… And then I start to realize how good I feel when I follow the app’s 
advice”. J.E.S. 
 
6.3.2 Game-life connection 
Several authors described how having an avatar in the game may help the player in 
real life. However, much in line with the abovementioned importance of linking the 
external and internal motivational drivers, it was found that the patients did not value the 
avatar primarily due to difficulties in relating it’s progression or deterioration to the 
progress and deterioration in their own life. In quote compilation E patients describe their 
predominantly negative experiences with using the avatar in HabitRPG. It may be argued 
that using an avatar with no real connection to real life turns the gamified system into a 
regular game distinct from the life of the player.  
Andreas Dam also states that: 
“If we want to keep patients motivated to use the app, it’s important to remember 
that the gamified app isn’t a game, it’s actually a service that is supposed to help you in 
some way or the other… And it’s important that you as a patient also experience this. So 
for example if you want to change your lifestyle over the next six months and you use the 
app for the purpose, then you need to be able to feel the results on your own body. Or at 
the doctor for example, your doctor prescribes a milder medication or other quality of life 
parameters. It has to be visual or something you can feel and understand. Even though 
gamification may be able to boost motivation, perhaps in waves, then I don’t think that 
gamification alone is enough. You need to be able to see some results and it has to make a 
difference”.  
This opinion is supported by the patient view: 
“If I eat an apple instead of candy, it’s not like I do it just because of the points. But 
it’s neither due to the feeling of being healthy, I mean, it’s more of a psychological thing. 
I think the two factors complement each other and I guess that’s why it feels so good. My 
health is reflected in the points and because eating an apple right here and right now 
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doesn’t make me slimmer or any different as I eat it, it’s nice to have my good deeds 
visualized in the app with rewards. […] When I first started using the app I did it mostly 
for the points and getting better. But as I began to compete and finish missions I felt that 
they were nicely aligned with what I wanted to achieve in real life. I think that in the long 
run, it’s important that I can feel the effect on my body and that it reminds me about what 
I can do”. J.E.S. 
 
6.3.3 A holistic approach to treatment 
One recurring topic amongst the patients was the idea of creating a gamified system 
that makes allowance for all aspects of the illness and treatment. Living with Diabetes is 
not only about taking medication. This and most other illnesses require changes in the 
patients’ lifestyle. The more holistic the app is and the better it is at considering and 
helping the patient with the entire spectrum of influential factors, the more motivated they 
are to use it.  
“What Dia+ does is just pure tracking that you may as well do in Excel in my 
opinion. It only focuses on the numbers and the insulin and that’s a shame. It feels like 
there’s nothing else to it, to the illness, than that, and that’s not really the truth with 
Diabetes.” M.W. 
The patient describes the app’s failure of integrating other aspects of Diabetes than 
measuring blood glucose levels. J.E.S. who uses HealthSeeker explains how this app is 
good at taking a holistic approach: 
“In the app there is a really good mix of the focus areas exercising, diet and 
medication. All the things that you need to consider as a patient”. 
Interestingly, the patient also points out that the app alone, despite incorporating 
several aspects of treatment, ought to contain or be connected to physical tracking 
devices: 
“The app competes with other apps in my phone , like Nike run for example. But if 
you could connect these two apps or alternatively have these monitoring functions in 
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HealthSeeker, the functions like those in Nike run, so you know, so it gives you a complete 
picture of your health. There should be some interconnection of data”. J.E.S. 
In quote compilation F, the experts elucidate how this holistic approach is becoming 
a central theme for the pharmaceutical organisations, not only to allow patients to address 
all aspects of their illness and treatment, but also to create a network of relations between 
the patient and the healthcare system, rather than looking at the patient in isolation when 
designing gamification.  
 
6.3.4 Overview 
One of the most valued features in all of the three gamified apps is the ability to 
create a graphical overview of the progress, which allows the user to revisit previously set 
goals and evaluate if these have been met.  
M.W. describes how the graphs easily illustrate your progress: 
“It’s something everybody understands, like in school when they replaced numbers 
with slices of pie, that was something everybody could understand. […] And when I see 
that my numbers on the graph are too far from the target number, it always turns into a 
competition for me, I actually start measuring more often”.  
In the patient’s description it is clear that graphical cause-and-effect illustrations 
that are comprehensible are far more motivational than construing random progress and 
regression based on memory and subjective experiences. According to Martin Simon 
Jørgensen, making your tracking uncomplicated, interesting and interpretable by 
visualizing the progress is an obvious effect that is warranted. He argues that: 
“If you can stay abreast then you can adapt the necessary things as you go along so 
you won’t get fluctuations in your blood sugar. If you can avoid these by having your 
finger on the pulse, on the blood sugar level, then you will avoid the harmful effects. […] 
What Glucodock does well is that it takes care of all the measurements and then it sends it 
to the app, which shows it graphically so that you can track the patterns of development 
and receive feedback in relation to the target numbers. So instead of having all these 
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isolated occurrences, which you forget quickly and which doesn’t teach you anything, 
then you can trace the patterns and it’s made much more transparent when you have some 
of these unfortunate fluctuations and you can see how you may have been able to stay 
within the desired intervals for a long time and, you know, sort of tie a history to this.” 
 
6.3.5 Sub-conclusion 
Internal and external drivers should be linked. Thus rewards in the gamified system 
must reflect feelings in the patient’s real life. This holds true both for digital rewards 
given directly to the patient and for rewards given indirectly to the patient via an avatar. 
Digital gamification has the potential of bridging the gap between internal and external 
drivers, as it may encourage patients to adopt a certain behavioural pattern because they 
think it is fun rather than because they are being told to do so. Furthermore, gamified apps 
can be used to visualize progress that cannot be felt immediately by the user, which makes 
it more motivating to keep engaging in a certain activity with no short-term benefits. One 
may also argue that the gamified app must produce a complete picture of the user’s health 
in a simplistic way. It must take a holistic approach and be characterized by all aspects of 
the treatment rather than addressing isolated factors. 
 
6.4 Perception of the industry 
6.4.1 Brand value 
Both the experts and the patients were asked questions related to the perceived 
purpose and outcome of using gamification. Several things can be inferred from the 
responses. From the experts’ point of view, they were able to give an account of why 
gamification may be a useful PR tool that can strengthen the organisation’s brand. 
Although gamification is directed at the patients, Andreas Dam argues that much of the 
brand value is created via patient organisations and physicians if their views on the 
gamified digital systems are positive (cf. quote compilation G). Thus gamification, 
although used by the patients, will potentially also gain value if applied as an indirect PR 
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tool directed at the patients via their caretakers. Andreas Dam further describes how 
gamified apps also support the organisations’ long-term business strategy. This discussion 
revolves around the future decision makers within the industry and how creating gamified 
apps may not depart as much from the original core business of creating medicine as one 
may think. Although medicine and devices remain the primary business, pharmaceutical 
sales and marketing in their original senses are argued to decrease massively in the future. 
The sales activities that pharmaceutical organisations are currently conducting towards 
physicians will disappear because socio-economics will become the future decision 
makers regarding prescribed medication. Within this scenario the experts argue that two 
extremes exist for which the pharmaceutical organisations must prepare: 
“One extreme is that pharma solely delivers medicine and their differentiation lies 
in their R&D phase… Who is better, faster and more proficient? Because there’s nothing 
else, nothing about the wrapping or having good sales people, all that has been removed 
so you exclusively look at the effect of the pill. […] In the other extreme scenario, which is 
much more likely and already starting to happen, we talk about value beyond the pill, 
which is thinking about health from a more holistic perspective. This means that you as a 
pharma company don’t just deliver the medicine, you deliver a variety of services that 
enable the patient to for example go to work, be more independent at home and what have 
you not. In this eco system pharma companies have the possibility of positioning 
themselves differently. […] Society will pay pharma companies for their expertise, so we 
have to re-think the whole value chain, where is it pharma should be positioned in the 
future?”.Andreas Dam. 
As seen in this argument, current key decision makers will be replaced and 
pharmaceutical organisations must adapt to this change. One way to deliver value beyond 
the pill and embrace the holistic approach to treatment is to create digital solutions that 
make use of gamification to motivate the users. Andreas Dam further posits that: 
“The best pharma companies right now are building some uniqueness and some 
differentiation via great digital solutions. Gamification, if applied correctly is one way of 
making the digital better and unique. Right now, the companies doing this may not get 
credit for this among socio-economics, but what they get right now is branding and 
goodwill with doctors and patients. So in the long run the socio-economics will look at 
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these services along with the medication and incorporate it in their algorithm and at that 
time it’s all about whether or not pharma companies have done a good job at building a 
critical mass and increased the quality of life and things like that, which make socio-
economics want to invest in it as they can see the positive effect on society or the 
individual. These companies will win in the long run”. 
The idea that gamified apps provide brand value is not limited to the experts’ 
thinking. In quote compilation H patients describe what they believe the pharmaceutical 
industry gains from creating these gamified apps that are free to download. Despite 
resolute assertions that the industry is, and always will be guided by economic interests, 
the patients accept this without letting it influence their opinion about the use of gamified 
apps. They appear to value the companies’ effort to approach them on a frequently used 
platform in a way that is fun and engaging. One of the patients, however, also depicts how 
the use of gamification is not invariably beneficial to the corporate brand, as a poorly 
designed gamified app will also link the user experience to the organisational image: 
”I became aware of Astra Zeneca through the app. Both in a good and a bad way, I 
think. For me it’s positive that they try to help and not sell, but given that their app isn’t 
really very helpful… Well, that isn’t exactly positive, is it?” D.S.P. 
 
6.4.2 Trust 
As described in the previous theme, there is a wish to generate brand value with 
digital gamification. One of the corner stones that will engender value is trust towards the 
organisation.The majority of the interviewed patients state that they are confident in the 
information they receive through the apps and that they see the development of these as a 
sign of the industry’s attempts to help patients. However, they also propound that 
pharmaceutical organisations are partially driven by monetary gains. Moreover, patients 
and patient organisations are getting better at interpreting the information they receive 
regarding health (Staton, 2014). Accordingly, one may argue that transparency and truth 
telling are the superior methods with which to win over the patients. Digital gamification 
denotes a situation where both the industry and the patients benefit from it. If done 
appropriately, this is a means to advocate greater trust towards the industry.  
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6.4.3 Sub-conclusion 
The value of digital gamification in the pharmaceutical industry not only lies in the 
relation that is created directly with patients but expands to value that is created through 
communication with caretakers and patient organisations. These are still a trusted source 
for patients, hence why a recommended app from healthcare professionals is likely to be 
taken seriously by the patients. Despite patients saying that pharmaceutical organisations 
are driven by monetary gains, they also believe that the gamified apps are created to help 
them, consequently increasing their trust towards the industry. The landscape is shifting 
and creating value beyond the pill will influence the future decision makers’ choice on 
preferred suppliers. Digital gamification is a method to deliver this value as it increases 
trust towards those companies engaging in it. Arguably, this will affect the position of the 
organisations, as those who successfully create value beyond the pill now will become 
more powerful industry leaders in the future.  
 
6.5 Digital gamification and the pharmaceutical industry 
6.5.1 Gamified apps for patients  
Contrary to deeming patients’ needs and their special situation as barriers for 
applying gamification in the pharmaceutical industry, these circumstances actually 
provide a strong incentive to employ gamification:  
“Even though everyone is a gamer to some degree, I think it’s easier for me as a 
diabetic to relate to these gamified elements because if you can combine them with 
something that is actually important then I think it’s even more motivating. I gain 
something extra from it and the results that you get, they are not just graphs or points or a 
score, they mean something for you and you can see and feel the physical results if the 
score fits the results. I don’t think very differently as a patient contra a healthy person 
when subjected to games and fun, but I do need the app to be more specific and 
explanatory, I think that’s necessary for me as a diabetic where everything isn’t 
necessarily obvious or easy”. M.W. 
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The patient describes how digital gamification is superior at spurring motivation 
because the changes that follow with using the app are highly important for his health. 
However, as stated by Andreas Dam, and which is also pointed out by patient M.W. the 
gamified app will only be successful if the gamification elements truly mirror the patient’s 
real life: 
“That’s the hardest thing about applying gamification to pharma, the whole process 
of ensuring that the elements like scoring systems are linked to, or that there is some 
clinical evidence linked to something relevant in the patient’s real life”. Andreas Dam. 
J.E.S. further explains that being part of a social community, like the one the apps 
provide, is even more important for diabetics than healthy people, who have access to this 
outside of the digital realm. 
 
6.5.2 Target group 
Using gamification in the pharmaceutical industry requires apprehension about the 
target group’s natural diversity. As argued by the patients and agreed upon by the experts, 
not all patients fall into the same category in terms of personality, needs, and emotional 
and motivational triggers: 
“There is a huge diversity in the patient segments, some are what we call 
empowered, some are very strong and want to be involved in the course of their disease 
while others are still, I don’t think that they have changed during the time I have been 
working with this, these are typically elderly or socially deprived or vulnerable groups”. 
Andreas Dam. 
Patients may come from various backgrounds and feel that this predicament is not 
something normal that other people struggle with, so why should they? This potentially 
obstructs the patients' interest in engaging with gamified systems designed to motivate 
behavioural change. Accordingly, Andreas Dam argues that for the gamified system to 
work, it is crucial that the target groups are involved when designing gamification: 
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“If you look at the process of creating gamification solutions they often end up 
pretty lousy. Many of these gamified activities or apps never really fly but rather become 
some marketing gimmick. Involving the right target group in the right way is extremely 
crucial when you design gamification and you can say that when just making information 
services then it’s easier to shoot in random directions, but when you’re making something 
that’s meant to motivate people then it’s important that you get it right regarding what 
motivates that specific group of people you work with. It mustn’t become a push activity, it 
has to be co-creational.” 
 
6.5.3 Sub-conclusion 
Gamification has the potential of altering behaviour amongst patients if a number of 
requirements are met. The developer has to co-create the app with the patients in order to 
accurately align the system with the situation and characteristics of the target group. 
These findings support those previously discussed by Glasemann and Kanstrup (2011), 
who concluded that patient’s emotions and perspectives on their own illness are 
paramount for the design of mobile technology support. Factors possibly perceived as 
obstructing digital gamification in the industry actually appear to induce motivation 
because the changes that follow with using the app are highly important for the patients’ 
health. 
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7. Discussion 	   	  
This chapter will relate the findings in the empirical data analysis to the research 
questions and theory discussed in the literature review. Table D recaps the questions that 
this study seeks to answer. 
Table D 
 
RQ1: “How is gamification suited for the pharmaceutical industry?” 
RQ2: “How can digital gamification be applied by pharmaceutical organisations to 
improve the relationship with patients?” 
RQ3: “How does the outcome of applying digital gamification in pharmaceutical 
organisations tie back to the business objectives?” 
 
The first question inquires about the appropriateness of applying gamification in the 
pharmaceutical industry. This question was asked in order to provide a breading ground 
for further investigation into how this can be done. It was discussed in the background 
chapter that if gamification can be used on patients, this would enable the industry to 
achieve numerous goals such as improving the relation with the patient stakeholders by 
means of motivating them to manage their own health and thereby being perceived as 
trustworthy. According to this research, using gamification to motivate certain behaviour 
amongst patients does appear to be possible. Although patients do constitute a special 
group of individuals with certain needs, they respond to features of gamification similarly 
to healthy individuals. Patients also seem to be even more motivated to engage in 
gamified systems because they have more at stake.  
What is especially intriguing about applying gamification in the pharmaceutical 
industry is the fact that it furnishes pharmaceutical organisations with the possibility of 
expanding their scope of communication while complying with the legislation. Using 
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gamification allows indirect interaction with patients without involving third parties, 
something that is otherwise strictly regulated in Europe. This interaction, which may 
engender brand awareness, can potentially affect the patients’ communication with their 
caretaker and eventually their choice of therapy. Likewise, communicating with patients 
can also happen via the caretakers, if the gamified system has been properly branded, so 
the caretaker will recommend the gamified app to the patient. Accordingly, a triangular 
communication model is created where pharmaceutical organisations can communicate 
with several stakeholders directly or indirectly through each other (See figure C). 
Figure C 
	  	  	  	  	  	  	  
 
As argued in the background chapter most patients feel more at ease with 
technology than ever before. This information was supported by the findings in the data. 
Patients have become more empowered, they communicate online and have access to all 
information related to themselves and their network on their phones. Accordingly, it is 
intelligible to communicate with them on digital platforms. A gamified mobile application 
is a way for pharmaceutical organisations to move into their consumers’ lives, as this is 
where much of their life is happening.  
While a number of challenges for pharma-patient interaction were described in the 
background information, several additional challenges were here identified. Patients live 
with every day issues that organisations must be able to understand, like they need to be 
able to understand their target groups’ divergent nature with many different types of 
people being classified as patients. So while the improved self-care has engendered more 
awareness about illnesses, which in turn has increased the wish to take action, every day 
challenges for diabetics may hinder that action is actually taken. Gamification has the 
Pharmaceutical	  organisation	  
Physician	  Patient	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potential of both increasing awareness and making the patients’ lives with their illness 
easier, but only when the system is designed to accurately target those challenges. 
Therefore, the development of gamified apps should be built on the fact that patients are 
individuals. Moreover, certain factors addressed below in the answer to RQ2 should also 
be accounted for. Thus although various barriers complicate the process of creating 
interaction through gamification, considerable opportunities suggest that gamification is 
well suited for the pharmaceutical industry. 
Second question seeks to establish what it requires for a gamified mobile application 
to function as a successful PR tool that will improve the relationship with patients. A 
number of theories were discussed in the literature review, which all described different 
elements such as points, leaderboards and competition that are necessary for gamification 
to be successful in forging long-term systemic changes where the user feel positive about 
engaging in the non-game activities. From analysing the interview data, several things can 
be concluded about gamification in the pharmaceutical industry versus regular 
gamification. Many of the elements result in similar reaction patterns in patients as in 
healthy people. Thus no features or approaches can be classified as unreservedly 
inapposite. Rather, a number of additional conditions must be incorporated in the design 
of gamification in the pharmaceutical industry. 
As argued by Zichermann (2012) and in the Theory of Gamification Effectivenes 
(Amir and Ralph, 2014), feedback to the user is required for the gamified system to 
function. This argument is supported by data derived from the interviews in this research. 
For patients, it appears that the feedback functions as a reminding friend or coach, who 
keeps track of the patients’ progress. Zichermann (2012) also states that the gamified 
system must contain a social network of friends. Although this also holds true in the 
pharmaceutical domain another social layer appears to be equally important for the 
gamified system to be optimally engaging. Having a social layer that encourages 
interaction with your caretaker and provides the possibility of sharing information with 
these will facilitate an improved dialogue between the patient and the physician, where 
focus lies on details and correlations that were previously invisible.  
As already mentioned, patients respond positively towards the majority of external 
rewards that academics, who build their theory on Operant Conditioning, describe as 
Page	  59	  of	  115	  
being the fundamental principles on which of gamification is based. Nevertheless, two 
additional things can be concluded about external rewards in pharmaceutical gamification. 
Firstly, this research suggests that rather than it being the scoring system per se that 
engenders motivation, the motivational feelings stem from the overview that is created. 
This is then supported by an external-based reward system as these scores, batches or 
levels further magnify the overview of progression. Secondly, external rewards must be 
applied only to the extent that they truly match the goals of the user. This was particularly 
clear when examining the patients’ experience with using the avatar in HabitRPG. The 
lack of connection between the avatar’s level and the patients’ own progress in life has a 
discouraging effect on behaviour.  
These arguments relate to The Kaleidoscope of Effective Gamification, which states 
that external rewards are of limited value and that adding these elements for the sake of 
reward will add no value to the gamification application. It is also in line with the 
situational relevance described by Nicholson (2012). The activities that patients are urged 
to engage in can more clearly be linked to their life if these are supported by explanations. 
Information therefore appears to be a centrepiece for patient gamification. 
Although most gamification designers ignore it, many academics point to the 
importance of scaffolding and guiding the user to understand the purpose of the gamified 
system and how to use it. One method with which the usage complexity can be made less 
convoluted is by providing sufficient information and by using a simple design. A 
simplistic design is key to successful gamification when targeting patients whose lives are 
already wrapped in complexity related to their illness and treatment. The gamified app 
needs to make their every day life with Diabetes easier and not be a confusing element.  
In the Self Determination theory, which focuses on what drives individuals to make 
choices without external influence, it was argued that conditions supporting autonomy, 
competence and relatedness would foster motivation. Although this cannot be entirely 
rejected, additional circumstances related to patients arguably complicate the original 
outline of the theory. In the literature review it was questioned how patients could be 
autonomous and set their own targets considering the intricacy of their situation. From 
analysing the data it is clear that patients must indeed feel autonomous for the gamified 
system to be engaging, but that detailed information must follow to guide the patients 
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when setting goals and explain how this relate to their health. The patients must also feel 
competent, but as stated in the Social Exchange Theory, the key is to identify the most 
appropriate rewards for the target user, so that the patient’s progression in the game is 
linked to progression in life. The third condition, relatedness, was argued to be either 
much less or much more important for patients. As many patients are without a physical 
support network of other patients, the digital network appears to be of utmost importance. 
Furthermore, the abovementioned additional layer of relatedness with the caretaker, who 
uses the overview in their evaluation process, also strengthens motivation. 
Consequently this research suggests that none of the three overarching theories of 
gamification or academic models are able to stand alone without moderation when applied 
in the pharmaceutical industry. Besides the additional conditions that have been 
mentioned, this study proposes a strong link to the Organismic Integration Theory (OIT) 
suggested by Deci and Ryan (1985). This theory is a sub-theory of the Self Determination 
Theory and explores how different types of external motivation can be integrated with the 
underlying activity into someone’s own sense of self. Rather than stating that motivations 
are initially internalized or not, this theory introduces a continuum based on the amount of 
external control that is integrated along with the desire to perform the activity (Nicholson, 
2012).  
As seen in this analysis gamification for patients has the potential of bridging the 
gap between internal and external motivation, thus facilitating the internalization of 
external rewards. Initially, the individual patients may learn to introject a behaviour that 
was first extrinsically motivated by for example points. But over time, as patients see the 
outcome of the induced behaviour, they may begin to internalize it, due to the positive 
feelings associated with it. At this stage, the patients will identify with the behaviour 
rather than merely introject it and thus engage in this particular behaviour to align it with 
the identity (Deci and Ryan, 2000). 
In addition to suggesting the OIT as being connected to gamification in the 
pharmaceutical industry, in-depth analysis of the qualitative data has qualified the framing 
of a model that is here proposed for digital gamification in the pharmaceutical industry. 
The model is rooted in traditional gamification theory and psychological theory of 
motivation, but incorporates some of the additional conditions that are found with 
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patients. The model, which is illustrated below and described in table E, attempts to 
demonstrate how various elements of gamification affect each other and how they are 
connected to motivation in patients. 
Figure D 
	  
	  
 
 
 
 
 
 
 
 
 
 
Table E 
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* Goals must be customized by the patient but guided by the app, which must provide 
information related to the goals. The types of goals must take a holistic approach and 
be varied to address all aspects of the patient’s illness and treatment.  
 
** External rewards must be linked to the patient’s real life. 
 
In the core of the model is the ultimate goal of digital gamification in the 
pharmaceutical industry; motivate behavioural change in the patient. With changed 
behaviour will physical well being follow, which in turn will cause behaviour to be 
self determined due to internalization of previously externally motivated actions, as 
stated in the OIT. Three primary parameters are concluded to have a direct link to 
motivation. Having an overview that highlights progress and regression makes the 
process more transparent and easier for the patient to work with. When the overview 
shows sign of improvement, the patient is motivated by the good work. When the 
overview shows sign of regression, the patient feels motivated to improve. External 
rewards such as points function as an indirect motivator that gamification ties to 
motivation via the overview. These tangible rewards reinforce the transparency in the 
overview. They are easy to grasp and illustrate progress very clearly, hence why the 
external rewards box feed into the overview box. Setting goals is also an indirect 
motivational feature that is related to the overview. They illustrate the direction in 
which the patient want to move in relation to the current overview, like the overview 
shows how far away from the goal the patient currently is. The second direct link to 
motivation is internal rewards. These are linked to the subjective feeling of joy, 
which is fostered by competition. Winning in turn stimulates the desire to further 
compete due to the positive associations, while losing may stimulate the desire to 
improve. Competition is also linked to the social network of other patients, which is 
another direct link to motivation. The social network of other patients consists of 
like-minded people with similar values and issues, meaning that the feeling of 
acknowledgement when winning or lack of this when loosing is more strongly shared 
between the members in the network. The other dimension of the social network is 
linked to healthcare professionals. They are not connected to competition and internal 
rewards, but are rather linked to goals and the overview, as the overview provides the 
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facilities for a quality dialogue with the caretaker, which can then, together with the 
patient, set some realistic goals. The external rewards are connected to the internal 
rewards via the OIT to illustrate how this theory lets the patient introject a behaviour 
that was originally motivated extrinsically due to the positive feelings associated with 
the outcome of conducting the particular behaviour. 
 
 
After establishing that digital gamification is suitable for patients and how it has to 
be adapted for these stakeholders, the third research question was asked to investigate 
whether the outcome of using gamification on patients was compatible with 
pharmaceutical organisations’ business objectives in the context of overall corporate 
goals. In order to answer this question, the business objectives initially had to be 
identified. This was done through a dialogue with the industry experts who were asked to 
pinpoint the purpose of using gamification with patients. It was discovered that the aim of 
applying gamification in the pharmaceutical industry is twofold. First objective can be 
perceived as part of a short-term PR strategy that will increase awareness, trust, and create 
a positive attitude towards the companies that apply gamification. This strategy is fruitful 
to the extent that the gamified app provides patients with a feeling that the company 
behind the app demonstrates a sincere wish to make their every day life more tolerable by 
means of providing motivation based on information wrapped in fun.  
The first objective’s success criteria also depend on the answers to the second 
research question, which attempts to answer how digital gamification can successfully be 
built to foster motivation and consequently enhance patient relations. Stating that the first 
objective is successfully met only partially reflects reality. From the interview data, it is 
clear that the companies have managed to generate a certain level of awareness. However, 
if the app provides no real value to the patient, no attitude or behavioural change will be 
induced.  
The second business objective for pharmaceutical organisations using digital 
gamification is linked to a long-term strategy rather than relying on short-term benefits 
related to the end consumers. As argued by Andreas Dam, the industry can win credibility 
among the allegedly future decision makers by demonstrating thought leadership and the 
ability to provide a more holistic solution that will increase quality of life. Thus, the 
Page	  64	  of	  115	  
organisations prepare for the future market by not only creating awareness and trust 
among the patients but also among politicians, socio-economics and patient organisations. 
Whether or not this objective is being met is yet unknown and future research into this 
matter is warranted. 
These different, yet connected business objectives of using digital gamification in 
the pharmaceutical industry can be illustrated in the stakeholder model proposed by Huhn, 
Sass and Storck (2011), which is a tool to indentify key stakeholders. 
 
Figure E 
 	  
	  	  
The model illustrates four classic stakeholder markets of corporate communication, 
which can be assigned to different communication functions (Watson and Noble, 2010). 
The long-term strategy of using gamification is related to financial communication where 
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the dialog unfolds between the organisation and the target groups representing the capital 
market including investors and analysts such as socio-economics. However, the long-term 
strategy also depends on external communication functions, which take care of the 
acceptance market, including politicians, to legitimize the social license to operate and to 
secure the organisational leeway. The short-term strategy is positioned within the market 
communication, which primary function is to create a corporate image and to build and 
ensure a sustainable relationship with e.g. customers and associations. 
 
 
 
 
 
 
 
 
 
 
 
 
 
8. Conclusion 	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In this thesis a previously researched topic (gamification) has been studied from a 
different perspective (healthcare) to explore how European pharmaceutical organisation 
can build and use gamified mobile application to improve relations with patients. Several 
conclusions are reached.  
Patients and industry experts both argue that awareness is important; constant 
reminders about healthy habits are pivotal for an improved lifestyle. Patients furthermore 
need to be motivated to act upon this and actively implement the required lifestyle 
changes. If pharmaceutical organisations succeed in helping the patients with overcoming 
challenges related to their illness by motivating them to enact the needed life style 
changes, it will increase the perceived trust towards their brand and thereby strengthen 
their relationship with the patients. This research argues that digital gamification is suited 
for this purpose, hence why it may be advantageous for organisation to incorporate digital 
gamification in their PR strategy. Nevertheless, the results also indicate that none of the 
prevailing models or overarching gamification theories sufficiently cover how digital 
gamification functions in the pharmaceutical industry. Although these theories provide 
relevant insight into the requirements and effects, certain conditions were found to be 
more important for patients than what is implied in the existing theories. These conditions 
include simplicity, guidance and adopting a holistic approach to treatment.  
Some of the most important factors, which are also addressed by other academics 
are having a social network and creating a link between the gamified system and the 
user’s real life. The additional social dimension with healthcare professionals, which is 
discussed in this research, highlights the strong need for creating an overview of the 
patients’ health and goals. This is something that is otherwise ignored by current theories 
but which ought to be incorporated in gamified systems for patients. By acknowledging 
these additional elements, positive communication effects can be achieved and a relation 
can be created with the patient stakeholders. Accordingly, successfully designed 
gamification is connected to the Organismic Integration Theory, as gamification will 
foster motivation and allows the patients to integrate externally induced behaviour into 
their internal system. This introjection occurs due to the positive outcome of the specific 
behaviour in the patient’s real life, which will be experienced in the long run. As such 
gamification is capable of bridging the gap between externally motivated behaviour and 
internally motivated behaviour. 
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It is concluded that using digital gamification is tied to two primary PR business 
objectives; one related to short-term benefits with a focus on creating awareness and trust 
with patients, another to a long-term strategy with a focus on market positioning in 
relation to politicians, patient organisations and particularly socio-economics; the future 
key opinion leaders. How the outcome of applying digital gamification is tied to these 
objectives depends on the ability of the organisations to acknowledge the additional 
elements of the gamified system that this study defines as essential when it is created for 
patients. If applied appropriately, gamification may be a useful PR tool to alter the 
perception of pharmaceutical organisations, which may give them a future competitive 
advantage in a market where new key opinion leaders and empowered patient 
stakeholders are shaping the landscape.  
However, future research is needed about the implications of the proposed 
additional elements of digital gamification and how gamification influences the 
perception of the industry among patients as well as socio-economics. This research has 
laid the foundation for further analysis and provides an elaborated model of digital 
gamification. This model outlines a number of proposed interrelated factors that influence 
the effect of digital gamification on the motivation to change behaviour in patients, which 
will in turn strengthen their relation with the pharmaceutical industry. 
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Appendix A 
Question guidelines, patients 
 
• Please start by telling me a little bit about who you are, for how long you’ve had Diabetes 
and what kind of treatment you are in. 
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• Do you do any thing else to stay in control of your Diabetes? (exercise/diet?) 
• Tell me a bit about the life with Diabetes; what challenges do you face in your every day 
life? 
o What does this mean for your social life? 
o What do you feel when this happens? 
 
• How much research on symptoms do you do yourself when you have, or think you have 
any? (Do you have an idea about what may be wrong before you see you doctor?) 
• Do you use the Internet to search for information about symptoms, treatments, good 
advice and so on? 
o What websites do you use? 
o Do you trust the information you get online? 
o To what degree do you trust the information you get from your doctor? 
o Why/why not? 
 
• Please, tell me about Dia+/HabitRPG/HealthSeeker 
• Why not/why does the app make it easier for you to live with your illness? 
• Is there something about the app that annoys you? 
o What and why? 
• What is the funniest part of the app? 
o Why? 
• What do you think about the different graphs and scoring systems? 
• How do you feel when you see your goals in such graphs or layouts? 
• How do you feel when your measurements aren’t close to your goals or recommended 
goals? 
• What do you think about the reminder or the push messages? 
• What do you think about the fact that you can share your progress and numbers with your 
phycisian? (Ask in cases where this is applicable).  
• Who do you/don’t you use the social functions in the app? 
• What do you think about the fact that you can set your own targets? (ask in cases where 
this is applicable)  
• Have you ever experienced a conflict between what you wanted to do (e.g. eat some 
cake) and what you had to do to reach your target (not eat some cake)? Describe. 
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• When you use the app, is it then primarily in order to make your graphs or score look 
better or is it because of your goal to become healthier? 
o Why? 
• Do you feel that there is a link between what you see and learn in the app and your 
improved life style? 
• Do you think that the app helps you control your lifestyle? 
o Why/why not 
• Do you think that this app can help all types of people with improving their health? 
• What would make the app better? 
• Do you think that the developer is trying to help you manage your health? 
• What do you think that the pharma industry gains from developing apps like this, which 
are free for patients to download? 
• What is you general opinion about the pharma industry? 
• Do you think that patients in general are just as/less/more susceptible to game elements?  
o Which ones and why? 
• Is there anything you want to add? 
• Thank you. 
 
 
 
 
 
 
 
 
Appendix B 
Questions guidelines, Martin Simon Jørgensen 
 
• Please, start out with telling me a bit about who you are and what you do. 
• For how long have you been working within this area? 
• Do you think that there has been a development in the way patients gather knowledge and 
information about symptoms, illnesses and treatments? (Elaborate with example) 
• How do you think this affects the pharma industry? 
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• Tell me about Glucodock and Vitadock – what is this all about? 
• What is the purpose of Clucodock and Vitadock? 
• What did your company want to achieve with this device? 
• What thoughts did you have about the design and the different elements/funtions of the 
app? (personalised comments, comparison, mood, feedback (star rating) and adverbs) 
• Why did you decide to focus on these things in particular? 
• What thoughts did you have about the target group? (Age/personalities/etc.) 
• What kind of effect do you want Clucodock to have on the target group? 
• What is it about Glucodock that will motivate the patients to keep using it? 
• What is it about Glucodock that will make the patient stick with the changed behaviour or 
attitude? 
• Do you think that Clucodock has an effect with regard to building a relation between the 
patients and the pharma industry?  
o Which? How? 
• What did primarily drive the development of Clucodock? (Who expressed a need?) 
• Do you think that the motivational factors of gamification can be copied from other 
industries to the pharmaceutical industry without further alterations?  
o Why? How? 
• How do you see the balance between making the patients do something (eg. Eat healthy 
food, workout, measure blood sugar levels) because they want to and because they have 
to?  
o Can you/how can you change that balance? 
• Where is Clucodock placed in relation to your corporate strategy? 
• What do you think companies gain from investing money in such devices or apps that are 
free or relatively cheap for the users to download/buy? 
• What does the future look like for gamification and the use of fun/game elements in the 
the pharma industry? 
• Do you want to add anything further? 
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Appendix C 
Question guidelines, Andreas Dam 
 
• Please, start out with telling me a bit about who you are and what you do. 
• For how long have you been working within this area? 
• Do you think that there has been a development in the way patients gather knowledge and 
information about symptoms, illnesses and treatments? (Elaborate with example) 
• How do you think this affects the pharma industry? 
• Tell me about your services – do you have an example where you use gamification, e.g. 
in an app? 
• What is the purpose of this (example)? 
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• What can a pharma company achieve with this? 
• What thoughts did you have about the design and the different elements/functions of the 
app? (personalised comments, comparison, mood, feedback (star rating) and adverbs) 
• Why did you decide to focus on these things in particular? 
• What thoughts did you have about the target group? (Age/personalities/etc.) 
• What kind of effect do you want the app to have on the target group? 
• What is it about the app that will motivate the patients to keep using it? 
• What is it about the app that will make the patient stick with the changed behaviour or 
attitude? 
• Do you think that the app has an effect with regard to building a relation between the 
patients and the pharma industry?  
o Which? How? 
• Do you think that the motivational factors of gamification can be copied from other 
industries to the pharmaceutical industry without further alterations?  
o Why? How? 
• How do you see the balance between making the patients do something (eg. Eat healthy 
food, workout, meause blood sugar levels) because they want to and because they have 
to?  
o Can you/how can you change that balance? 
• Where is the app placed in relation to the corporate strategy of the company who is 
making app made? 
• What do you think companies gain from investing money in such devices or apps that are 
free or relatively cheap for the users to download/buy? 
• What does the future look like for gamifiation and the use of fun/game elements in the 
the pharma indutry? 
• Do you want to add anything further? 
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Appendix D 
Complete transcript of interview with Martin Simon Jørgesen 
 
The highlighted text is what the researcher deemed particularly important and the accompanying 
text in the left column is the researchers own notes that was later used for data reduction and 
coding of themes. 
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Appendix	  E	  
Consent	  form,	  patients	  
	  
 
Lund University, Department of Strategic Communication 
MSc Strategic Public Relations 
 
Informed Consent 
 
 
 
This Informed Consent Form is for Danish patients suffering from Diabetes type-1, who are 
invited to participate in the research project ‘Gamification in the Pharmaceutical Industry’. 
 
 
_________________________________________________________ 
Name of Principle Investigator 
 
 
_________________________________________________________ 
Name of Organisation  
 
 
_________________________________________________________ 
Name of Project  
 
This Informed Consent Form has two parts:  
• Information Sheet (to share the purpose of the study with you)  
• Certificate of Consent (for signatures if you choose to participate)  
 
You will be given a copy of the full Informed Consent Form  
 
Part I: Information Sheet  	  
I,	  Nanna	  Birkedal,	  graduate	  student	  at	  Lund	  University,	  am	  writing	  my	  Master	  Thesis	  on	  the	  use	  
of	   gamification	   in	   the	   pharmaceutical	   industry.	   Please	   ask	  me	   at	   any	   point	   prior	   to,	   during	   or	  
after	   the	   interview	   has	   taken	   place	   if	   you	   have	   any	   doubts	   or	   questions	   related	   to	   the	   consent	  
form	  or	  the	  research	  in	  general.	  
	  
This research will involve your participation in an interview that will take about one hour. 
 
Purpose	  of	  the	  research	  	  This	  research	  attempts	  to	  explore	  how	  pharmaceutical	  organisations	  can	  improve	  the	  dialogue	  with	   patients	   and	   help	   them	  managing	   their	   disease	  without	   necessarily	   doing	   this	   through	  third	   parties	   such	   as	   physicians.	   The	   focus	   is	   on	   the	   use	   of	   gamification	   (using	   game-­‐based	  elements	   in	   non-­‐game	   contexts)	   and	   what	   elements	   of	   this	   are	   best	   applied	   in	   the	  pharmaceutical	  industry.	  
 
	  
	  
	  
Page	  99	  of	  115	  
Participant	  Selection	  	  You	  are	  being	  invited	  to	  take	  part	  in	  this	  research	  because	  it	  is	  estimated	  that	  your	  experience	  as	  a	  type-­‐1	  Diabetic	  can	  contribute	  much	  to	  the	  understanding	  and	  knowledge	  of	  gamification	  practices	  in	  the	  pharmaceutical	  industry.	  
 
Procedures	  	  During	  the	  interview,	  I,	  Nanna	  Birkedal,	  will	  sit	  down	  with	  you	  in	  a	  comfortable	  place	  agreed	  upon	  by	  us	  both.	  If	  you	  do	  not	  wish	  to	  answer	  any	  of	  the	  questions	  during	  the	  interview,	  you	  may	  say	  so	  and	  I	  will	  move	  on	  to	  the	  next	  question.	  No	  one	  else	  but	  me	  will	  be	  present	  unless	  you	  would	  like	  someone	  else	  to	  be	  there.	  The	  information	  recorded	  is	  confidential,	  and	  no	  one	  else	   except	  me	  will	   have	   access	   to	   the	   information	   documented	   during	   your	   interview.	   The	  entire	  interview	  will	  be	  recorded,	  but	  no	  one	  will	  be	  identified	  by	  name	  in	  the	  recording.	  The	  information	  recorded	  is	  confidential	  and	  will	  only	  be	  used	  for	  academic	  purposes.	  	  
	  
Voluntary	  Participation	  	  Participation	  and	  the	  right	  to	  withdraw	  at	  any	  time	  are	  voluntary,	  so	  that	  no	  individual	  will	  be	  coerced	  into	  participation.	  
 
You will be asked to share some perhaps sensitive or personal information, and should you feel 
uncomfortable talking about some of the topics, you do not have to answer the questions. You do not 
have to give me any reason for not responding to any question, or for refusing to take part in the 
interview. 
 
There will be no direct benefit to you, but your participation is likely to help me find out more about 
how to improve disease management and the dialogue between patients and pharmaceutical 
organisations by means of gamification. 
 
 
Part II: Certificate of Consent  	  
I have been invited to participate in research about gamification in the pharmaceutical industry. 
	  
I	   have	   read	   the	   foregoing	   information,	   or	   it	   has	   been	   read	   to	   me.	   I	   have	   had	   the	  
opportunity	   to	   ask	   questions	   about	   it	   and	   any	   questions	   I	   have	   been	   asked	   have	   been	  
answered	  to	  my	  satisfaction.	  I	  consent	  voluntarily	  to	  be	  a	  participant	  in	  this	  study	  	  
	  
	  
_______________________________________________________________	  
Print	  Name	  of	  Participant	  
	   	   	   	  
	  
_______________________________________________________________	   	  
Signature	  of	  Participant	  	  
 
 
_______________________________________________________________ 
Date	  –	  Day/month/year	  
	   	   	   	  	  
	  
 
I	  have	  accurately	  provided	  information	  to	  the	  potential	  participant,	  and	  the	  individual	  has	  
had	   the	   opportunity	   to	   ask	   questions.	   I	   confirm	   that	   the	   individual	   has	   given	   consent	  
freely.	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_______________________________________________________________	  
Print	  Name	  of	  Researcher	  
	  
	  
_______________________________________________________________	   	  
Signature	  of	  Researcher	  
 
 
_______________________________________________________________ 
Date	  –	  Day/month/year	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  F	  
Consent	  form,	  experts	  
	  
 
Lund University, Department of Strategic Communication 
MSc Strategic Public Relations 
 
Informed Consent 
 
 
 
This Informed Consent Form is for Danish employers working with gamification or areas 
related to this, who are invited to participate in the research project ‘Gamification in the 
Pharmaceutical Industry’. 
 
 
_________________________________________________________ 
Name of Principle Investigator 
 
 
_________________________________________________________ 
Name of Organisation  
 
 
_________________________________________________________ 
Name of Project  
 
This Informed Consent Form has two parts:  
• Information Sheet (to share the purpose of the study with you)  
• Certificate of Consent (for signatures if you choose to participate)  
 
You will be given a copy of the full Informed Consent Form  
 
Part I: Information Sheet  	  
I,	  Nanna	  Birkedal,	  graduate	  student	  at	  Lund	  University,	  am	  writing	  my	  Master	  Thesis	  on	  the	  use	  
of	   gamification	   in	   the	   pharmaceutical	   industry.	   Please	   ask	  me	   at	   any	   point	   prior	   to,	   during	   or	  
after	   the	   interview	   has	   taken	   place	   if	   you	   have	   any	   doubts	   or	   questions	   related	   to	   the	   consent	  
form	  or	  the	  research	  in	  general.	  
	  
This research will involve your participation in an interview that will take about one hour. 
 
Purpose	  of	  the	  research	  	  This	  research	  attempts	  to	  explore	  how	  pharmaceutical	  organisations	  can	  improve	  the	  dialogue	  with	   patients	   and	   help	   them	  managing	   their	   disease	  without	   necessarily	   doing	   this	   through	  third	   parties	   such	   as	   physicians.	   The	   focus	   is	   on	   the	   use	   of	   gamification	   (using	   game-­‐based	  elements	   in	   non-­‐game	   contexts)	   and	   what	   elements	   of	   this	   are	   best	   applied	   in	   the	  pharmaceutical	  industry.	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Participant	  Selection	  	  You	  are	  being	  invited	  to	  take	  part	  in	  this	  research	  because	  it	  is	  estimated	  that	  your	  experience	  as	  an	  expert	  within	  the	  industry	  can	  contribute	  much	  to	  the	  understanding	  and	  knowledge	  of	  gamification	  practices	  in	  the	  pharmaceutical	  industry.	  
 
Procedures	  	  During	  the	  interview,	  I,	  Nanna	  Birkedal,	  will	  sit	  down	  with	  you	  in	  a	  comfortable	  place	  agreed	  upon	  by	  us	  both.	  If	  you	  do	  not	  wish	  to	  answer	  any	  of	  the	  questions	  during	  the	  interview,	  you	  may	  say	  so	  and	  I	  will	  move	  on	  to	  the	  next	  question.	  No	  one	  else	  but	  me	  will	  be	  present	  unless	  you	  would	  like	  someone	  else	  to	  be	  there.	  The	  information	  recorded	  is	  confidential,	  and	  no	  one	  else	   except	  me	  will	   have	   access	   to	   the	   information	   documented	   during	   your	   interview.	   The	  entire	  interview	  will	  be	  recorded,	  but	  no	  one	  will	  be	  identified	  by	  name	  in	  the	  recording.	  The	  information	  recorded	  is	  confidential	  and	  will	  only	  be	  used	  for	  academic	  purposes.	  	  
	  
Voluntary	  Participation	  	  Participation	  and	  the	  right	  to	  withdraw	  at	  any	  time	  are	  voluntary,	  so	  that	  no	  individual	  will	  be	  coerced	  into	  participation.	  
 
You will be asked to share some perhaps sensitive or confidential information, and should you feel 
uncomfortable talking about some of the topics, you do not have to answer the questions. You do not 
have to give me any reason for not responding to any question, or for refusing to take part in the 
interview. 
 
There will be no direct benefit to you, but your participation is likely to help me find out more about 
how to improve disease management and the dialogue between patients and pharmaceutical 
organisations by means of gamification. 
 
 
Part II: Certificate of Consent  	  
I have been invited to participate in research about gamification in the pharmaceutical industry. 
	  
I	   have	   read	   the	   foregoing	   information,	   or	   it	   has	   been	   read	   to	   me.	   I	   have	   had	   the	  
opportunity	   to	   ask	   questions	   about	   it	   and	   any	   questions	   I	   have	   been	   asked	   have	   been	  
answered	  to	  my	  satisfaction.	  I	  consent	  voluntarily	  to	  be	  a	  participant	  in	  this	  study	  	  
	  
	  
_______________________________________________________________	  
Print	  Name	  of	  Participant	  
	   	   	   	  
	  
_______________________________________________________________	   	  
Signature	  of	  Participant	  	  
 
 
_______________________________________________________________ 
Date	  –	  Day/month/year	  
	   	   	   	  	  
	  
 
I	  have	  accurately	  provided	  information	  to	  the	  potential	  participant,	  and	  the	  individual	  has	  
had	   the	   opportunity	   to	   ask	   questions.	   I	   confirm	   that	   the	   individual	   has	   given	   consent	  
freely.	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_______________________________________________________________	  
Print	  Name	  of	  Researcher	  
	  
	  
_______________________________________________________________	   	  
Signature	  of	  Researcher	  
 
 
_______________________________________________________________ 
Date	  –	  Day/month/year	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Appendix G 
Diabetes: Aetiology, risk factors, and treatment 
 
Diabetes is a group of metabolic diseases in which the person has high blood glucose (blood 
sugar). This is due to either inadequate insulin production, or the fact that the body's cells do not 
respond properly to insulin, or in rare cases both. Insulin is a hormone that converts sugar, 
starches, and other food into that energy the body needs to function properly (American Diabetes 
Association, n.d.).  
 
Normally the two types of Diabetes are labelled type-1 and type-2.  
 
Diabetes type-1 
This type of Diabetes is sometimes called “juvenile” diabetes, because it usually develops in 
children and teenagers, though it can develop at any age. With type-1 Diabetes, the body’s 
immune system attacks part of its own pancreas. The immune system mistakenly sees the insulin-
producing beta cells in the pancreas as foreign, and thus destroys them. This attack is known as 
autoimmune disease. These cells, called islets, are the ones that sense glucose in the blood and, in 
response, produce the necessary amount of insulin to normalize blood sugars. Insulin serves as a 
“key” to open cells, to allow the glucose to enter and allow the body to use the glucose for 
energy.  Without insulin, there is no “key.” Accordingly, the sugar is not removed from the 
blood. As a result the body’s cells starve from the lack of glucose. If left untreated, the high level 
of “blood sugar” can damage several bodily functions and organs such as eyes, kidneys, nerves, 
and the heart. If uncontrolled, the illness will be fatal (diabetesresearch, 2014).  
 
The therapy used for treating Diabetes type-1 is typically insulin injections in combination with a 
healthy lifestyle. This external source of insulin functions as the missing “key” that brings 
glucose to the cells. The challenge with this treatment is that it is difficult to know the exact 
amount of insulin that should be injected. The amount is based on many factors, including food, 
exercise, stress, emotions, and general health. As these factors fluctuate greatly throughout the 
day, deciding on what dose of insulin to take is a complicated balancing act. Taking too much the 
body will burn too much glucose causing the blood sugar to drop to a dangerously low level. This 
condition is called hypoglycemia. Taking too little, on the other hand, will mean that the body is 
starved of the energy it needs causing the blood sugar to rise to a very high level; a condition 
called hyperglycemia, that can also cause long-term complications.  
 
Diabetes type-2 
The other type of Diabetes is much more common, and is non-insulin dependent. This is also 
called “adult onset” diabetes, since it typically develops after age 35. With type-2 Diabetes the 
body is insulin resistant, meaning that the body does not use the insulin properly. At first, the 
pancreas makes extra insulin to compensate for this, but over time it cannot keep up and produce 
the required amount of insulin for the blood glucose to normalize.  
 
Often, type 2 is tied to people who are overweight, with a sedentary lifestyle, although genetics 
may also be a contributing factor. Treatment focuses on diet and exercise. If blood glucose levels 
remain high, oral medications may used to help the body use its own insulin more efficiently. In 
some cases, insulin injections are necessary (diabetesresearch, 2014).  
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Appendix H 
Participant overview 
 
The Experts: One interview was with the System Manager & Advanced Business Analyst, Martin 
Simon Jørgensen from Novo Nordisk, who has previously worked for Steno Diabetes Center4 and 
who was also part of the team that developed and launched the device ‘GlucoDock’5  and the app 
VitaDock funded by Medisana. The other expert interview was carried out with Andreas Dam, the 
CEO of Daman; an agency working with design and implementation of digital media strategies for 
pharmaceutical businesses.  
 
The patients: Six patients were interviewed for this thesis. The participant sample is a mix of type 
1- and type-2 diabetics and they were contacted through Danish networks for Diabetes on facebook 
and on the Danish Diabetes Association’s blog. All patients are anonymously participating in this 
research, hence why only their initials are shown. The three tables below give a short description 
of their illness, history, treatment, and what gamified app they use or have previously used. 	  	  	  	  	  	  	  	  	  	  	  	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  4	  Steno Diabetes Center, which is working in partnership with the Danish healthcare system, 
is a non-for-profit organisation owned by Novo Nordisk A/S. The center treats approximately 
5600 people with Diabetes and has four main focus areas: Education, health promotion 
research, patient care, and biomedical research. 
5 A small device containing elements of gamification. It is attached to an iphone/ipad and 
allows the user to automatically measure glucose levels, set goals, keep track of food intake, 
etc. with the connected app VitaDock.	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Dia+	  
M.W.	  
Type-­‐1	  Diabetic	  
Age	  29	  Currently	  uses	  insulin	  pump.	  Previosuly	  used	  needles.	  	  Very	  active	  (runs	  several	  times	  every	  week)	  Measures	  blood	  glucose	  several	  times	  every	  day.	  Diabetic	  since	  	  2002	  
R.H.K	  
Type-­‐2	  Diabetc	  
Age	  36	  Uses	  needles	  Moderately	  active	  Measures	  blood	  glucose	  5	  times	  every	  day	  and	  counts	  carbs	  	  Diabetic	  since	  2014	  
HealthSeeker	  
J.E.S.	  
Type-­‐1	  Diabetic	  
Age	  31	  Just	  started	  on	  insulin	  pump.	  Previosuly	  used	  needles.	  	  Not	  very	  active	  	  Measures	  blood	  glucose	  3-­‐4	  times	  every	  day.	  Diabetic	  since	  1999	  
P.N.	  
Type-­‐2	  Diabetc	  
Age	  44	  Uses	  needles	  Moderately	  active	  Measures	  blood	  glucose	  2-­‐3	  times	  every	  day	  Diabetic	  since	  2014	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HabitRPG	  
D.S.P.	  
Type-­‐1	  Diabetic	  
Age	  28	  Uses	  needles	  Fitness	  one	  time	  every	  week	  Measures	  blood	  glucose	  	  3	  times	  every	  day.	  Diabetic	  since	  2005	  
L.E.W.H.	  
Type-­‐2	  Diabetc	  
Age	  37	  Uses	  needles	  Moderately	  active	  Measures	  blood	  glucose	  2-­‐3	  times	  every	  day	  Diabetic	  since	  2009	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Appendix I 
Description of mobile applications 
 
Application #1: Dia+  
Dia+ is an app created by the Danish Diabetes association and the two pharmaceutical 
organisations AstraZeneca and Bristol-Myers Squibb. With diabetics in mind, the main functions 
of this app are to keep a diary of e.g. blood sugar levels, blood pressure, doctor visits, mood, BMI 
and cholesterol levels. A barometer, graphs, and social sharing opportunities let the users compare 
their own levels with standard, recommended levels. All data concerned with blood sugar has to be 
entered in the app every time the user has measured this. 
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Application #2: HealthSeeker  
HealthSeeker is developed by the Diabetes Hands Foundation in collaboration with Joslin Diabetes 
Center to motivate better lifestyle choices by people living with Diabetes and engage them in 
improving both their nutritional and physical health. It was made possible through financial 
support provided by Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly USA, LLC. This 
app allows the user to choose from a number of different action steps and missions, each related to 
one of four categories6. When accomplishing these, the user is rewarded with points and 
experience, which will allow the user to increase in levels. The user can also collect kudos, which 
are virtual pads-on-the-backs that only can only be given away to other players as a show of 
support. Every time a user picks a mission a detailed description follows about the healthy benefits 
the user will gain from completing the mission and what the specific mission is important for a 
healthy lifestyle.  	  
	   	  	  
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
6 Healthy living, maintaining a low weight, controlling diabetes and eating nutritiously 
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Application #3: HabitRGP 
HabitRPG, which is created by OCDevel LLC, is a habit-building app that rewards users for their 
successes and penalizes them for slip-ups. It provides external motivation for completing day-to-
day activities, contains social elements (competition and sharing) and the app treats the user’s 
goals like a role playing game with each user having an avatar. The users choose their own tasks to 
complete, which requires that they are able to come up with these themselves. For each tasks that is 
completed the user levels up and can win badges as well as virtual coins or diamonds with which 
the user can buy gadgets for his or her avatar. It is also possible to join challenges created by other 
users. However, if the user is inactive, does not finish the tasks or engage in bad habits, points will 
be subtracted and the avatar will eventually die. 	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Appendix J 
Quote compilations 
 
The following quotes are included in the appendices to highlight and strengthen the points made in 
this research. 
 
Quote compilation A 
M.W.: “The last couple of years I have become more aware of various symptoms, especially 
because of potential sequelae and I usually have some idea about what could be the issue before I 
see the doctor. Normally I use Google to find out and then I end up on a site where people express 
their opinions and experiences. But more often I use netdoktor, which I end up on via Google, it 
appears more trustworthy than some discussion forum on Jubii.”  
L.E.W.H.: “I typically use netdokotor.dk and I also use Google a lot, but I’m always critical. 
I mean, it takes two minutes to create a website, ten minutes to make it look nice.” 
D.S.P.: “If I hear about illnesses or treatments I don’t already know, I normally search 
online for more information to understand what it is. I usually Google it, but I also use netdoktor a 
lot. I would say that this gives me a pretty good idea about the condition, but I never really trust 
the information 100%, I mean… If it’s a professional site I usually trust it, but if the info is from a 
private person I tend to be more critical.” 
J.E.S.: “When I hear about new research or treatment methods I often read about it either 
online or in diabetesforeningen’s7 own magazine, they have a section about this. Like, when I first 
heard about the insulin pump I, well, at first I didn’t think too much about it, but after a while I 
asked my doctor to get one. He had to determine whether or not I was eligible to get it.” 
J.E.S “I prefer to look at expert’s sites, so the manufacturer’s website or a Diabetes site. It’s 
not very often I use online discussion forums because even though some of the experiences may be 
the same among the participants, the underlying reasons to these experiences are not necessarily 
the same.”  
 
Quote compilation B 
J.E.S.: “Exercising requires and active choice and I often see that as a hurdle […]. I know 
it’s an important part of my treatment, so I try to do as much as possible. But there are so many 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
7 Diabetesforeningen is the Danish Diabetes Association (www.diabetes.dk)  
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other things that goes on all the time, I have just moved and things like that, so it’s hard to… Well, 
both find the time, but also to remind yourself of the importance of finding the time.” 
P.N: “I have some very busy days, I mean, no single day is the same as the one before, with a 
student job and university and all, and it’s pretty easy to forget all these things I have to do. And 
also to stay focused on it, I mean, there are so many other things that I would rather do than 
injecting insulin or eating a carrot.” 
J.E.S.: ”The biggest issue with having Diabetes is not because it interferes with my social 
relations, but I think that’s because I have a tendency to let it slip to the back of my mind”. 
Martin Simon Jørgensen:”As you can read in most Diabetes groups on Facebook and other 
places, the thing that annoys the majority of diabetics, a battle that they fight, is that an illness… 
This condition, mustn’t take up too much space and time in their life. That’s not what life is all 
about. Life is meant to be lived and this is just something that you have to handle on the side. So… 
perhaps that’s also why some patients make the deliberate choice to not care too much about it 
and the balance… How do you create… how do you make it possible to focus on all sorts of things 
at the same time as having this under control”. 
D.S.P: “I remember this one episode from when I was younger and my class was going to 
Copenhagen. Then the teacher had to come home to me and learn how to inject the insulin, 
because my mum couldn’t come on the trip… She always had to join the class when we slept over 
somewhere and I remember that this was pretty annoying.” 
 
Quote compilation C 
L.E.W.H.: “The best function of HabitRPG is the ability to customize. I really like that you 
can define your own goals… What your success criteria is. But at the same time this is also 
problematic because as a Diabetic you probably need some guidelines about what goals you 
should set. There are examples of goals in the app, but these are not really explained or… They 
stand alone, they are just ideas without a reason”. 
L.E.W.H.: “When I started using the app I remember looking for some sort of introduction 
that just wasn’t there. Only on the computer, which I became aware of later. I mean, I could see 
that you could add your own tasks and use some pre-added ones like eat junk food and loose 
points, I have had to do that a few times recently. But why is that bad and other things good? I 
mean okay, eat junk food is a no brainer, but how does these things affect my Diabetes? […] Let’s 
say I just got extra points for eating fish, a certain type, salmon, that’s rich in omega 3 fatty acids, 
then it should explain to me why this is helpful in relation to my condition or my health. Maybe nut 
a fun fact, because it’s probably not funny, but you know, a fact. That’s something I feel is missing 
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in HabitRPG, because it is parenting 1-0-1, you know, education, so in general if you tell a  child 
‘do this’ then the child will think ‘nope’… Or ‘why’. If there is no accompanying information 
telling the child ‘because’ then the app will loose it’s opportunity of educating in some way 
because if you don’t have the underlying understanding then you are not as motivated to try ”. 
 
Quote compilation D 
Andreas Dam: “We want to build a social network where the users can talk to each other 
across boarders and meet like-minded people in a closed and anonymous forum, because it may be 
a little private to suffer from something and not everyone wishes to share their identity” 
Martin Simon Jørgensen: “It has a rather positive effect that you can share the information 
like this with your physician, because then you can have a storyline to talk about, making it a 
quality dialogue about how things actually go.” 
 
Quote compilation E 
P.N.: “It took me a while to understand what the rise in level meant for my character. 
Whether it actually affected it at all… But if you actually read and understand the system it makes 
sense that the different characters have different skills. But I sort of miss the link between my 
character’s skill set and my own skill set. I mean, when I buy gear for my character it gets better 
equipped for withstanding damage for instance, but I don’t always feel better equipped myself”. 
D.S.P.: “Buying the things for my avatar didn’t trig me. I mean, I couldn’t really see the 
point or relate it to me. I have my avatar and when you buy something for it with your earned 
coins, it changes looks. But it’s sort of not within any context, there’s no landscape or story about 
it or anything, just a picture and then it doesn’t really matter. I don’t really feel the connection 
between the levels and… You know, the connection between my avatar’s levels and mine. […] I 
don’t feel that my lifestyle changes in line with the health status of the avatar. It sort of becomes 
two different things”. 
 
Quote compilation F 
Andreas Dam: ”I think it’s important that when you think about the design of gamification 
not just look at the patient in isolation but rather look at the whole network of relations between 
the patient and the health system and the healthcare professionals. Because even though the 
doctors no longer have the same degree of authority, there is still some degree of trust in them and 
people still see them as the experts.” 
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Andreas Dam: “The future use of gamification is definitely related to this holistic approach. 
It’s meant to have a motivating effect and it contains some elements that push patients to do things 
they wouldn’t have done otherwise”. 
Martin Simon Jørgensen: “From the app you will be able to gather all information, just like 
Steno has this site where all health information is saved, the app actually does the same, where it 
will connect with some sort of other devices that Medisana makes, like instruments that measure 
blood pressure, fat percentage, temperature and those things, so everything. All these devices that 
you can use to measure your health and treat yourself with, it will be able to gather in the app”. 
 
Quote compilation G 
Andreas Dam: “Gamification has a great potential as a CSR project or a corporate project 
where you sell or brand you name, but not your products. It can amend the loyalty issue with 
patients although the core business is still on a product level, that’s where they make their money 
and if that doesn’t happen, then there’s no company”. 
Andreas Dam: “The value lies in the perception of the brand among the doctors, which is 
spread to the patients. The doctors know that they are unable to see the patients all the time, so if 
something can be done in that time where the patients are left to themselves, then that is really 
good… And you have all the derived value, like the data you collect, which cannot be used directly 
by the pharma organisations, but it can be used for research. You can get some insight into the 
lives of the patients that you don’t even know are parameters today, something that influences their 
condition”. 
Andreas Dam: “What we see is a possibility to influence the relationship between the patient 
and the pharma company with this app through patient organisations. I don’t think that a great 
gamified app will influence the relationship between the pharma company and the individual 
patient that much though. Perhaps they will have been made aware of the brand, and awareness is 
one thing I guess, the first step to changing attitude in the long run, but the short term effects will 
not be between the individual patient and pharma. Of course there is some brand value involved 
and the company will probably gain some attention on their CSR investment, but this is here that 
Novo Nordisk will approach Steno or the doctors and say ‘hey, we have this great app’ and the 
next time the doctor sees a patient he may recommend the app for free.” 
 
Quote compilation H 
L.E.W.H: “I think that there are two aspects of why the pharma industry invests money and 
time in developing these gamified apps that are free to download for the patients. There is CSR, 
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that’s something you are very interested in as a pharma company, and then of course because you 
get your name on it. It’s an easy way to create a co-relation between your brand name and the fact 
that you work with an illness”. 
D.S.P.: “Making gamified apps as a pharma company is… I see it both as a PR stunt and as 
a necessity. People are living their lives on their phones so it’s sort of the next step for all 
industries. Why shouldn’t pharma involve their users? It’s a natural development to include digital 
games. […] Of course it is also about publicity and it makes sense for pharma to go digital because 
the patients are digital. Personally I think they are trying to help by using gamification like this, 
but there’s no denying that they care about their image as well. Especially in front of the rest of the 
world, so the media and the doctors for example If they have a bad reputation and create an app 
that everyone loves, then it will overshadow the bad publicity ”. 
D.S.P: “I acknowledge that the industry is a money making machine, but that’s fair enough, I 
don’t really have a choice. They are the ones who help me live after all. What I don’t acknowledge 
is the moment pharma starts making their money on desperate people. Diets and weight loss is 
something people are paying attention to and I think you can convince a lot of people about what 
ever they want to believe.” 
J.E.S.: “I believe that the industry wants the best for me, but I accept that they are also here 
to make money. That’s why it can get a little obscure and you need to make sure that the treatment 
you choose is in fact your own choice and not only based on the recommendation from someone 
who has more than one interest in this”. 
J.E.S.: “I didn’t know much about Boehringer Ingelheim before I used HealthSeeker. But 
now I think it demonstrates their commitment to the area and I trust them to genuinely attempt to 
help people live a better and easier life. That’s the signal they send. I think that pharma creates 
awareness amongst patients that help them and that they want to be where the patients are, the 
newest platforms.” 
M.W.: […] They provide the clients with some tools that will make their life easier and more 
fun. I think it positions them as one of the top players that they are modern and adapt their 
business model to the patients. They do what they can to integrate the illness into the patients’ 
every day life to simplify things and to encourage them to make the right choices”. 
 	  
